TIDMVLS
RNS Number : 9516Z
Velocys PLC
18 May 2023
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR
INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF
AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH
AFRICA OR JAPAN OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR
SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS
NOT AN OFFER TO SELL OR A SOLICITATION TO BUY SECURITIES IN ANY
JURISDICTION, INCLUDING THE UNITED STATES OF AMERICA, CANADA,
AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR JAPAN IN
WHICH SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL OR TO ANY PERSON
TO WHOM IT IS UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION. NEITHER
THIS ANNOUNCEMENT NOR ANYTHING CONTAINED HEREIN SHALL FORM THE
BASIS OF, OR BE RELIED UPON IN CONNECTION WITH, ANY OFFER OR
COMMITMENT WHATSOEVER IN ANY SUCH JURISDICTION.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF ARTICLE 7 OF REGULATION 2014/596/EU AS IT FORMS PART OF THE LAW
OF ENGLAND AND WALES BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL)
ACT 2018. IN ADDITION, MARKET SOUNDINGS WERE TAKEN IN RESPECT OF
THE MATTERS CONTAINED IN THIS ANNOUNCEMENT, WITH THE RESULT THAT
CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION. UPON THE
PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW
CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL
THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.
18 May 2023
Velocys plc
("Velocys", the "Company" or the "Group")
Proposed Placing, Retail Offer and Open Offer
Proposed conditional issue of Convertible Loan Notes led by
strategic investor, Carbon Direct Capital
Placing, Retail Offer and Open Offer to provide funds through
expected key value inflection points for the Company in relation to
the Altalto Project and Bayou Fuels Project
Additional capital raise to support significant scale-up and
ambition to become a leading provider of Sustainable Aviation Fuel
solutions
Velocys plc (AIM: VLS) (the "Company"), the sustainable fuels
technology company, announces its intention to raise approximately
GBP6 million in aggregate before expenses by way of a conditional
Placing (the "Placing") at the price of 2.5 pence per Placing Share
(the "Issue Price") together with a retail offer to existing retail
Shareholders on the BookBuild Platform at the Issue Price (the
"Retail Offer"). The Company is also announcing an open offer of
new Ordinary Shares at the Issue Price (the "Open Offer") and a
proposed conditional issue of convertible loan notes ("Convertible
Loan Notes") to Carbon Direct Capital, and potential further
issuances of Convertible Loan Notes and/or new Ordinary Shares to
investors other than Carbon Direct Capital (together with the
Placing and Retail Offer the "Fundraise").
The Placing will be effected through the issue of new Ordinary
Shares (the "Placing Shares") to new and existing investors.
The Retail Offer will be for up to 20,000,000 new Ordinary
Shares at the Issue Price on the BookBuild Platform (the "Retail
Offer Shares") to raise up to approximately GBP0.5 million (before
expenses) to provide existing retail Shareholders in the United
Kingdom with an opportunity to participate in the Fundraise. A
separate announcement will be made in due course regarding the
Retail Offer and its terms. For the avoidance of doubt, the Retail
Offer is not part of the Placing.
In order to provide Shareholders who have not taken part in the
Placing or the Retail Offer with an opportunity to participate in
the proposed Fundraise, the Company is also offering Eligible
Shareholders the opportunity to subscribe, at the Issue Price, for
an aggregate of up to 77,648,390 new Ordinary Shares (the "Open
Offer Shares"), to raise up to approximately GBP2 million via the
Open Offer.
Strategic investor, Carbon Direct Capital, has conditionally
agreed to subscribe for a minimum of $15 million (approximately
GBP12 million) of the Convertible Loan Notes subject to, inter
alia, the Company raising or having received legally binding
commitments in respect of the Minimum Amount. Further details on
the terms of the Convertible Loan Notes are set out in paragraph 6
of Appendix I.
Carbon Direct Capital, which is based in New York, US, is a
growth investment firm focused on carbon management technologies.
Carbon Direct Capital believes that selective investing with a
scientific approach maximises both climate benefits and financial
returns. Carbon Direct Capital has partnered with a number of
transformative carbon tech companies across two growth equity funds
and is the lead investor in the proposed conditional issue of the
Convertible Loan Notes. Carbon Direct Capital's subscription of a
minimum of $15 million of the Convertible Loan Notes will become
unconditional provided that, among other things, the Minimum Amount
Condition is satisfied, by the CLN Long Stop Date.
The Convertible Loan Notes are unsecured and have been
structured to incentivise a US Listing of the Company, in addition
to its existing admission to trading on AIM, within 21 months from
the date of completion of the issuance of Convertible Loan Notes to
Carbon Direct Capital (" US Listing ") . A number of discussions
are underway with additional potential Convertible Loan Note
investors.
Funds raised through the Placing, the Retail Offer and the Open
Offer will be used primarily to provide growth capital in
preparation for significant scale-up and working capital through
expected key valuation inflection points for the Altalto Project
and the Bayou Fuels Project with additional funds intended to be
raised through the issue of the Convertible Loan Notes to Carbon
Direct Capital and potential further issuances of Convertible Loan
Notes and/or New Ordinary Shares to drive the Company's technology
delivery capability and to provide balance sheet strength whilst
continuing to build a revenue generating pipeline.
Placing, Retail Offer and Open Offer Highlights
-- The Placing will be conducted by way of an accelerated
bookbuild process at the Issue Price (the "Bookbuild"), which will
be launched immediately following this announcement in accordance
with the terms and conditions set out in Appendix II.
-- The Company is also launching a Retail Offer to eligible
existing retail Shareholders at the Issue Price and a separate
announcement regarding the Retail Offer will be made shortly.
-- Subject to the successful closing of the Bookbuild, the
Company is also making an Open Offer, for up to 77,648,390 Open
Offer Shares, to raise up to approximately GBP2 million at the
Issue Price, on the basis of 1 Open Offer Share for every 18
Existing Ordinary Shares held by Eligible Shareholders at the
Record Date. Any entitlements to Open Offer Shares not subscribed
for by Eligible Shareholders will be available to Eligible
Shareholders under an excess application facility for the Open
Offer.
-- It is expected that certain Directors and senior management
in the Company will subscribe for New Ordinary Shares through the
Placing for an aggregate amount of approximately GBP75,000. Further
details will be announced as appropriate in due course.
Convertible Loan Notes Highlights
-- Proposed conditional issue of Convertible Loan Notes of
which, to date, $15 million (approximately GBP12 million) have been
conditionally subscribed for by Carbon Direct Capital.
-- Ongoing discussions with potential strategic co-investors in the Convertible Loan Notes.
-- Issue of the Convertible Loan Notes to Carbon Direct Capital
is conditional on, amongst other things, the Company having raised
or having received legally binding commitments in respect of the
Minimum Amount from the Fundraise.
-- The Convertible Loan Notes have been structured to
incentivise a US Listing of the Company, in addition to its
existing admission to trading on AIM, within 21 months from
completion of the issuance of Convertible Loan Notes to Carbon
Direct Capital.
-- The Convertible Loan Notes convert into new Ordinary Shares
upon a US Listing, or earlier as may be elected by the CLN
Investors, at a conversion price equivalent to the Issue Price,
which may be adjusted downwards in the event that the Company
undertakes a further equity raise at a lower subscription price per
share prior to Conversion.
-- The Convertible Loan Notes are unsecured and have zero coupon
for the first 21 months from issue. If the Company achieves a US
Listing within this 21-month period or the Convertible Loan Notes
are otherwise redeemed or converted by such date, the Convertible
Loan Notes will not bear interest. If not, an annualised interest
rate of 12.5 per cent. will apply from the date of issuance of the
Convertible Loan Notes which shall accrue in varying monthly
coupons.
Use of Proceeds
-- The net proceeds of the Placing, the Retail Offer and the
Open Offer will be used primarily for:
o organisation costs including project delivery and business
development;
o engineering scale-up with investment in engineering
resource;
o initial commissioning of the Ohio manufacturing facility;
and
o working capital requirements to invest in achieving supply
chain resilience and to cover timeline of grant receipts.
-- In the event of the Minimum Amount being raised, the net
proceeds of the issuance of the Convertible Loan Notes to Carbon
Direct Capital and the issuance of further Convertible Loan Notes
and/or Ordinary Shares to investors other than Carbon Direct
Capital will be used primarily for:
o scaling-up of the organisation and corporate costs including
increasing labour from approximately 40 full time employees to
approximately 100 full time employees gradually over the next 12 to
18 months in line with client and project demand in order to
accelerate the capability of the Company to deliver its technology
to its clients at scale;
o completion of capital investment in the Ohio reactor core
manufacturing facility including production start-up and catalysis
upgrades;
o funding for US Listing costs or interest payments due on the
Convertible Loan Notes in the event no US Listing occurs during the
21-month period from issue of the Convertible Loan Notes;
o supporting performance guarantees for the Company's
proprietary Fischer-Tropsch technology to be delivered to client
projects; and
o working capital requirements, build-up of reactor inventory at
the Ohio manufacturing facility and to manage timing of payments
and grant receipts.
Company Highlights
-- Velocys is an international sustainable fuels technology
company with patented technology enabling scalable production of
drop-in, net zero, sustainable aviation fuel ("SAF").
-- It delivers a competitive and commercially demonstrated
Fischer-Tropsch Synthesis solution using solid feedstocks or
hydrogen from renewable power and CO .
-- Velocys' conversion pathway enables negative carbon intensity
fuels via CO(2) sequestration of between 30 per cent. and 40 per
cent. of the feedstock carbon used.
-- Capital light, scalable licensing model with revenues from
technology licencing, engineering services, and Company reactor and
catalyst supply over the lifetime of refineries. The Company
generates both upfront and recurring fees .
-- High growth market driven by decarbonisation mandates and
incentives with increasing policy support (UK, US, Europe,
Canada).
-- Accelerating its commercialisation strategy by advancing two
full-scale biorefinery Reference Projects (Altalto Project in the
UK and the Bayou Fuels Project in the US) to generate significant
revenue for the Company and accelerate technology adoption. The
Reference Projects provide a blueprint for future customers.
-- Appointment of Bechtel, a leading worldwide provider of
engineering, construction and project management services, as SAF
project delivery partner to provide front end project engineering
and other technical services to Velocys' SAF project portfolio.
-- Significant progress of the Bayou Fuels Project:
o highly favourable US climate legislation announced in the
second half of 2022;
o appointment of a leading global investment bank to lead
funding for project development capital which is expected to close
during the last quarter of 2023;
o project economics significantly enhanced following improved
carbon intensity score through the provision of biomass boiler
renewable power solution with carbon capture integration; and
o 100 per cent. of expected project SAF output is subject to an
offtake agreement or memorandum of understanding for offtake.
-- Significant progress of the Altalto Project:
o GBP27 million grant from the UK Department for Transport (DfT)
awarded in December 2022 under the Advanced Fuels Fund and
consequential commencement of Front End Engineering Design ;
and
o appointment of a leading global investment bank to lead the
matched funding capital raise required for the DfT grant. The
project fundraise is expected to close during the last quarter of
2023.
-- The business development pipeline continues to grow, with a
number of feasibility studies underway with both biorefinery and
advanced power-to-liquid developers, as well as a significant
increase in enquiries for potential projects. The Company expects
to move forward with a number of new clients over the course of
2023.
-- Engineering services contract with Toyo in Japan continues.
-- Construction of the Company's new reactor core manufacturing
facility in Columbus, Ohio has been completed, with commissioning
commencing in the second half of 2023. This will significantly
increase the Company's capacity to deliver Fischer-Tropsch
synthesis technology solutions to its clients.
Henrik Wareborn, Chief Executive of Velocys, said:
"There is global recognition of the urgent need to replace
fossil derived fuels with sustainable equivalents in order to
tackle climate change. Velocys provides a unique technological
pathway to the economic production of drop-in sustainable aviation
fuel, which can decarbonise the aviation industry without the need
for any aircraft engine modification. Put simply: we believe that
we have a ready-to-go solution to the challenge of making aviation
environmentally sustainable. The commitment from Carbon Direct
Capital, which has partnered with a number of transformative carbon
tech companies, to conditionally subscribe for a minimum of $15
million of convertible loan notes provides further demonstration of
the increasing global awareness and expert validation of Velocys'
proprietary technology.
"We have a highly scalable business model, partnerships with
some of the world's leading technology companies and airlines, and
a growing business development pipeline. We are well-positioned now
to move on to the next stage of our growth, and we are excited by
what the future has in store.
"Our ambition is to become a leading provider of innovative SAF
solutions to enable the decarbonisation of the aviation
industry."
Further details relating to the Fundraise
The Issue Price of 2.5 pence per New Ordinary Share represents a
discount of 26.9 per cent. to the closing mid-market price of 3.42
pence per Existing Ordinary Share as at 17 May 2023.
The Placing Shares are not being made available to the public.
It is envisaged that the Bookbuild will be closed no later than
11.00 a.m. GMT tomorrow, 19 May 2023 but may be closed earlier, or
later, at the discretion of the Joint Bookrunners. Details of the
number of Placing Shares will be announced as soon as practicable
after the closing of the Bookbuild (on 19 May 2023). The Placing,
the Retail Offer and the Open Offer are not underwritten.
The Fundraise is conditional on, inter alia, the passing of the
Resolutions by the Shareholders at the General Meeting to be held
at 10.30 a.m. on 8 June 2023 at Magdalen Centre, Robert Robinson
Avenue, The Oxford Science Park, Oxford OX4 4GA . The Placing, the
Retail Offer and the Open Offer are not conditional on the issue of
the Convertible Loan Notes or on the Minimum Amount being raised.
The Retail Offer and the Open Offer are conditional upon completion
of the Placing. The Placing is not conditional upon any of the
Retail Offer, the Open Offer, the issue of the Convertible Loan
Notes or any future fundraise to raise the Minimum Amount.
Subscription by Carbon Direct Capital for Convertible Loan Notes is
conditional on the Company having raised or having received legally
binding commitments in respect of the Minimum Amount from the
Fundraise. Should Shareholder approval for the Resolutions relating
to the Placing, the Retail Offer and the Open Offer not be obtained
at the General Meeting, none of the Placing, the Retail Offer or
the Open Offer will proceed. Should Shareholder approval for all
Resolutions not be obtained at the General Meeting, the proposed
conditional issue of Convertible Loan Notes to Carbon Direct
Capital and/or other investors will not proceed. The Placing,
Retail Offer and Open Offer are not conditional on the passing of
the Resolutions relating to the Convertible Loan Notes.
Set out below in Appendix I is an adapted extract from the
Circular that is proposed to be sent to Shareholders after the
closure of the Bookbuild and which provides further information on
the Company, the Placing, the Retail Offer, the Open Offer and the
proposed conditional issuance of the Convertible Loan Notes. The
final Circular, containing the terms and conditions of the Open
Offer and Notice of General Meeting will be sent to Shareholders
and published on the Company's website on or around 22 May
2023.
Terms and conditions of the Bookbuild are set out in Appendix
II.
The capitalised terms not otherwise defined in the text of this
announcement are defined in Appendix III and the expected timetable
of the principal events is set out in Appendix IV.
This summary should be read in conjunction with the full text of
the following announcement.
Enquiries:
Velocys
Henrik Wareborn, CEO
Philip Sanderson, CFO +44 1865 800821
Panmure Gordon (UK) Limited (Nomad, Joint Bookrunner
& Joint Broker)
Hugh Rich (Corporate Broking)
Emma Earl (Corporate Finance)
John Prior (Corporate Finance)
Mark Rogers (Corporate Finance) +44 20 7886 2500
Shore Capital Stockbrokers Limited (Joint Bookrunner
& Joint Broker)
Henry Willcocks (Corporate Broking)
Toby Gibbs (Corporate Advisory)
James Thomas (Corporate Advisory)
Angus Murphy (Corporate Advisory) +44 20 7408 4090
Radnor Capital (Investor Relations)
Joshua Cryer
Iain Daly +44 20 3897 1830
Buchanan (Financial PR) +44 7 872 604 453
Helen Tarbet +44 7979 497 324
Simon Compton velocys@buchanan.uk.com
Notes to Editors
About Velocys
Velocys is an AIM quoted, international sustainable fuels
technology company, providing customers with a technology solution
to enable the production of negative Carbon Intensity synthetic,
drop-in fuels from a variety of waste materials. Synthetic fuel is
the only commercially available, permanent alternative to fossil
aviation fuels. The Velocys technology is IP-protected in all major
jurisdictions.
Two reference projects in the US and UK (Bayou Fuels and Altalto
respectively) are designed to accelerate the adoption and
standardise the Velocys proprietary Fischer Tropsch (FT) technology
with an integrated end to end solution, including renewable power
and sequestration.
Velocys is enabling commercial scale synthetic fuel production
in response to the clean energy transition, with significant
additional positive air quality impacts.
www.velocys.com
About Carbon Direct Capital
Carbon Direct Capital is a New York, US, based growth investment
firm focused on carbon management technologies. The firm believes
that selective investing with a science focused approach maximizes
both climate impact and financial returns. Carbon Direct Capital
has partnered with a number of transformative carbon tech companies
across two growth equity funds. To learn more, visit
www.carbondirectcapital.com .
NOT FOR PUBLICATION , DISTRIBUTION OR RELEASE DIRECTLY OR
INDIRECTLY, IN WHOLE OR IN PART IN OR INTO THE UNITED STATES OF
AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH
AFRICA OR JAPAN OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR
SALES WOULD BE PROHIBITED BY APPLICABLE LAW.
IMPORTANT NOTICES
IMPORTANT NOTICE
The information contained in this announcement is for
information purposes only and does not purport to be full or
complete. The information contained in this announcement is given
at the date of its publication (unless otherwise marked) and is
subject to updating, revision and amendment from time to time. No
reliance may be placed for any purpose on the information contained
in this announcement or its accuracy, fairness or completeness.
Neither this announcement, nor any copy of it, may be taken or
transmitted, published or distributed, directly or indirectly, in
or into any jurisdiction where to do so would constitute a
violation of the relevant securities laws of such jurisdiction.
This announcement is for information purposes only and does not
constitute an offer to sell or issue, or the solicitation of an
offer to buy, acquire or subscribe for any shares in the Company in
any state or jurisdiction in which such offer or solicitation is
not authorised or to any person to whom it is unlawful to make such
offer or solicitation. Any failure to comply with these
restrictions may constitute a violation of securities laws of such
jurisdictions.
This announcement is not for publication or distribution,
directly or indirectly, in or into the United States of America.
This announcement is not an offer of securities for sale into the
United States. The securities referred to herein have not been and
will not be registered under the U.S. Securities Act of 1933, as
amended (the "US Securities Act"), and may not be offered or sold
in the United States, except pursuant to an applicable exemption
from registration. No public offering of securities is being made
in the United States.
The contents of this announcement have not been reviewed by any
regulatory authority in Hong Kong. You are advised to exercise
caution in relation to the Placing. If you are in any doubt about
any of the contents of this announcement, you should obtain
independent professional advice. This is not an offer to the public
and the Placing Documents (as defined below) will not be registered
as a prospectus under the Companies (Winding Up and Miscellaneous
Provisions) Ordinance (Cap. 32 of the laws of Hong Kong) or any
other applicable ordinance in Hong Kong.
This announcement must not, therefore, be distributed, issued,
circulated or possessed for the purpose of distribution or issue or
circulation, to persons in Hong Kong other than (1) to professional
investors within the meaning of the Securities and Futures
Ordinance (Cap. 571 of the laws of Hong Kong) (including
professional investors falling within the Securities and Futures
(Professional Investors) Rules (Cap. 571D of the laws of Hong
Kong)) or (2) in circumstances which would not constitute an offer
to the public for the purpose of the Companies (Winding Up and
Miscellaneous Provisions) Ordinance (Cap. 32 of the laws of Hong
Kong) or the Securities and Futures Ordinance (Cap. 571 of the laws
of Hong Kong).
This announcement has been issued by, and is the sole
responsibility of, the Company. No undertaking, representation,
warranty or other assurance, express or implied, is made or given
by or on behalf of the Company, Panmure Gordon (UK) Limited
("Panmure Gordon") or Shore Capital Stockbrokers Limited ("Shore
Capital") or any of their respective directors, officers, partners,
employees, agents or advisers or any other person as to the
accuracy or completeness of the information or opinions contained
in this announcement and no responsibility or liability is accepted
by any of them for any such information or opinions or for any
errors, omissions or misstatements, negligence or otherwise in this
announcement.
Panmure Gordon is authorised and regulated in the UK by the FCA
and is acting as nominated adviser and joint broker to the Company.
Panmure Gordon is not acting for, and will not be responsible to,
any person other than the Company for providing the protections
afforded to its customers or for advising any other person on the
contents of this announcement or on any transaction or arrangement
referred to in this announcement. No representation or warranty,
express or implied, is made by Panmure Gordon as to, and no
liability is accepted by Panmure Gordon in respect of, any of the
contents of this announcement. The responsibilities of Panmure
Gordon as the Company's nominated adviser under the AIM Rules for
Companies ("AIM Rules") and the AIM Rules for Nominated Advisers
are owed solely to London Stock Exchange plc and are not owed to
the Company or to any director or Shareholder of the Company or any
other person, in respect of his decision to acquire shares in the
capital of the Company in reliance on any part of this
announcement, or otherwise.
Shore Capital is authorised and regulated in the UK by the FCA
and is acting as joint broker to the Company. Shore Capital is not
acting for, and will not be responsible to, any person other than
the Company for providing the protections afforded to its customers
or for advising any other person on the contents of this
announcement or on any transaction or arrangement referred to in
this announcement. No representation or warranty, express or
implied, is made by Shore Capital as to, and no liability is
accepted by Shore Capital in respect of, any of the contents of
this announcement.
The information in this announcement may not be forwarded or
distributed to any other person and may not be reproduced in any
manner whatsoever. Any forwarding, distribution, reproduction, or
disclosure of this information in whole or in part is unauthorised.
Failure to comply with this directive may result in a violation of
applicable securities laws and regulations of other
jurisdictions.
This announcement contains (or may contain) certain
forward-looking statements with respect to certain of the Company's
current expectations and projections about future events and the
Company's future financial condition and performance. These
statements, which sometimes use words such as "aim", "anticipate",
"believe", "may", "will", "should", "intend", "plan", "assume",
"estimate", "expect" (or the negative thereof) and words of similar
meaning, reflect the current beliefs and expectations of the
directors of the Company and/or the Joint Bookrunners and involve
known and unknown risks, uncertainties and assumptions, many of
which are outside the Company's control and difficult to predict,
that could cause actual results and performance to differ
materially from any expected future results or performance
expressed or implied by the forward-looking statement. The
information contained in this announcement speaks only as of the
date of this announcement and is subject to change without notice
and the Company does not assume any responsibility or obligation
to, and does not intend to, update or revise publicly or review any
of the information contained to this announcement, whether as a
result of new information, future events or otherwise, except to
the extent required by the FCA, the London Stock Exchange or by
applicable law.
Any information in this announcement in respect of past
performance (including without limitation past performance of the
Company, its group, shares in the Company and/or the Company's
portfolio) cannot be relied upon as a guide to future performance.
The price of shares and the income from them may fluctuate upwards
or downwards and cannot be guaranteed.
This announcement contains inside information as defined in
Regulation (EU) No. 596/2014 on market abuse which is part of UK
domestic law by virtue of the European Union (Withdrawal) Act 2018
("MAR") and is made in accordance with the Company's obligations
under article 17 of MAR. The person responsible for arranging the
release of this announcement on behalf of Velocys is David Bate,
General Counsel of Velocys.
APPIX I
The Fundraise
1. Introduction
The Company proposes to raise, subject to certain conditions:
(i) approximately GBP6 million (before expenses) in aggregate by
way of a conditional Placing of new Ordinary Shares at the Issue
Price to certain institutional and other investors and by way of a
Retail Offer to eligible retail Shareholders through the issue of
up to 20,000,000 Retail Offer Shares at the Issue Price on the
BookBuild Platform (details of which will be announced in a
separate announcement in due course); and (ii) up to approximately
GBP2 million (before expenses) by way of an Open Offer made to
Eligible Shareholders of up to 77,648,390 Open Offer Shares at the
Issue Price. The Issue Price represents a discount of 26.9 per
cent. to the closing mid-market price of the Ordinary Shares as at
17 May 2023 of 3.42 pence per Ordinary Share.
In addition, the Company intends to raise a minimum of $15
million (approximately GBP12 million) through the proposed issue of
Convertible Loan Notes to Carbon Direct Capital and further amounts
to satisfy the Minimum Amount Condition through potential further
issuances of Convertible Loan Notes and/or new Ordinary Shares to
investors other than Carbon Direct Capital. This strategic
investment in the Convertible Loan Notes is being led by Carbon
Direct Capital which has entered into the Commitment Letter for the
proposed subscription and issue by the Company, subject to the
satisfaction of the conditions set out therein, of Convertible Loan
Notes with a subscription value of $15 million (approximately GBP12
million). The maximum amount that may be raised by the Company
pursuant to the Fundraise is GBP50 million.
Carbon Direct Capital is a New York, US, based growth investment
firm focused on carbon management technologies. The firm believes
that selective investing with a scientific approach maximises both
climate benefits and financial returns. Carbon Direct Capital has
partnered with a number of transformative carbon tech companies
across two growth equity funds.
The Convertible Loan Notes are structured to incentivise a US
Listing of the Company, in addition to its existing admission to
trading on AIM . The Convertible Loan Notes are unsecured and
automatically convert into Ordinary Shares at the Conversion Price
upon US Listing. The Convertible Loan Notes will not bear interest,
provided that Velocys achieves a US Listing prior to the 21-month
anniversary of the issue of the Convertible Loan Notes. Further
details on the terms of the Convertible Loan Notes are set out in
paragraph 6 of this Appendix I. Discussions are ongoing with
additional potential Convertible Loan Note investors.
The Directors have been considering the merits of a US Listing
for some time, given Velocys' Bayou Fuels Project and technical
centre in the US, favourable pro-sustainable fuels legislation, and
the large number of US specialist institutional investors. The
Directors believe that a dual listing will further enhance the
Company's reputation and increase global awareness of the Company's
proprietary technology. This funding provides the impetus and
support for progressing these plans.
Funds raised through the Placing, the Retail Offer and the Open
Offer will be used primarily to provide growth capital in
preparation for significant scale-up and working capital through
expected key valuation inflection points for the Altalto Project
and Bayou Fuels Project with additional funds intended to be raised
through the issue of the Convertible Loan Notes to Carbon Direct
Capital and potential further issuances of Convertible Loan Notes
and/or new Ordinary Shares to investors other than Carbon Direct
Capital to drive the Company's technology delivery capability and
to provide balance sheet strength whilst continuing to build a
revenue generating pipeline. Further details on the use of proceeds
are set out in paragraph 5 of this Appendix I.
The Placing, the Retail Offer, the Open Offer and the issue of
the Convertible Loan Notes to Carbon Direct Capital, are each
conditional upon, amongst other things, the passing of certain
Resolutions in order to ensure that the Directors have the
necessary authorities and powers to allot the New Ordinary Shares
and issue the Convertible Loan Notes. A General Meeting is
therefore being convened for the purpose of considering the
Resolutions at 10.30 a.m. on 8 June 2023 at Magdalen Centre ,
Robert Robinson Avenue, The Oxford Science Park, Oxford OX4 4GA.
The Notice of General Meeting will be set out at the end of the
Circular . The Placing, the Retail Offer and the Open Offer are
also conditional on, inter alia, the Placing Agreement between the
Company and the Joint Bookrunners becoming unconditional and not
being terminated in accordance with its terms. The Placing, the
Retail Offer and the Open Offer are not underwritten. The Placing,
the Retail Offer and the Open Offer are not conditional on the
issue of the Convertible Loan Notes. Subscription by Carbon Direct
Capital for the Convertible Loan Notes is conditional on the
Company having raised or having received legally binding
commitments in respect of the Minimum Amount from the Fundraise.
The Minimum Amount Condition has not currently been satisfied.
2. Information on the Company
(a) Overview of the Company
Velocys is an international sustainable fuels technology
company, providing clients with one of the most sustainable routes
to the economic production of drop-in SAF from a variety of waste
materials. Velocys operates a capital light and scalable licencing
model offering a technology solution for the development of
synthetic sustainable fuels manufacturing via its proprietary
patented micro-channel Fischer-Tropsch reactors and comprehensive
biorefinery integrated technology package. The Company has offices
in Oxford, UK as well as Houston, US and reactor manufacturing
facilities in Ohio, US.
Velocys has a number of third party clients to whom it supplies
its technology; in addition, Velocys is developing two full-scale
biorefinery Reference Projects:
a) the Bayou Fuels Project in Mississippi, US which will utilise
woody waste to produce sustainable fuels
b) and the Altalto Project in Immingham in the UK which will
process municipal and commercial solid waste into sustainable
fuels.
The Reference Projects are being developed to accelerate
adoption of the Group's technology. Following the completion of
third party construction capital project financing and commencement
of the detailed engineering stage of these projects, the Reference
Projects are expected to generate significant technology licensing
revenue for the Group. Further details of each of the Reference
projects is set out in sections e) and f) below. Velocys is
building a strategic and financial partner network to attract new
investors to the Reference Projects. As a consequence of new
investors entering into the projects, Velocys expects its equity in
the projects to be significantly diluted.
The Company's near-term ambitions are focused on creating
sustainable shareholder value by growing the customer pipeline,
progressing its biorefinery Reference Projects in the UK and US
into FEED (Front End Engineering Design) delivery and revenue
generation. Fees will start being generated as the Reference
Projects enter into their FEED phase which will generate revenues
through the execution of technology licenses and engineering
services agreements. The Company is also focused on expansion of
its commercial and business development functions, and engineering
and reactor manufacturing to support the scale-up of its
business.
The Company's aim is to become a leading provider of innovative
SAF solutions to enable the decarbonisation of the aviation
industry. The Company is moving towards achieving these ambitions
whilst creating sustained shareholder value through a diverse
client pipeline delivering significant one-off and recurring
revenues.
The Group's technology has been commercially demonstrated
through several customer projects since 2015 following the
manufacturing of commercial reactors and catalysts: in 2017 a first
commercial demonstration plant (the ENVIA plant, located in
Oklahoma, US) using two of the Group's full-scale Fischer-Tropsch
reactors and catalyst was completed and subsequently produced a
fuel output that qualified under the Renewable Fuels Standard and
was sold to commercial clients. Subsequently, construction of the
NEDO I biomass demonstration project in Japan was successfully
completed in late 2020 using the Group's proprietary
Fischer-Tropsch technology. 3,000 litres of fuel from NEDO I were
used in a Japan Airlines scheduled commercial flight in June 2021
becoming the first such flight using SAF derived from woodchips
feedstock at any scale. Further details of these commercial
demonstration plants are provided below.
In November 2021, the Group signed a 15-year fixed price offtake
agreement with Southwest Airlines and a memorandum of understanding
for a 10-year fixed price offtake with IAG for in aggregate 100 per
cent. of the SAF to be produced and environmental credits generated
from the Bayou Fuels Project. The Directors believe that these
offtake agreements further validate the demand for the Group's
technology and will significantly de-risk the Bayou Fuels Project
which should enable construction capital financing of the project.
Through the combination of biogenic feedstock, planned renewable
power supply and carbon capture and storage (both currently in the
pre-FEED phase), Velocys' micro-channel Fischer-Tropsch reactors
and comprehensive biorefinery integrated technology package will
enable the commercial-scale production of SAF at the Bayou Fuels
Project with a deeply negative prospective Carbon Intensity of
-375g CO(2) e/MJ, which is expected to achieve a total of 1.3
million tonnes of avoided CO(2) per annum over the term of the
contracts equivalent of 1.1 million return economy trips from San
Francisco to London per year. Following the implementation of the
highly beneficial Inflation Reduction Act in the US in August 2022,
Velocys has appointed a leading global investment bank to raise
FEED funding for the Bayou Project which is expected during the
last quarter of 2023.
The Altalto Project is currently being developed in conjunction
with British Airways who have an option over 50 per cent of the
project. As announced on 12 December 2022, Altalto Limited has
secured a grant from the UK Department for Transport (DfT) under
the Advanced Fuels Fund up to a maximum of GBP27 million for the
Altalto Project. The grant funding, which will be distributed over
the 3-year grant period through to March 2025 and is conditional on
private-sector matched funding over the course of the grant period,
will enable Altalto to complete the critical FEED stage of the
project. Altalto Limited has completed the work necessary to claim
the first tranche (GBP7 million) of the grant up to 31 March 2023.
In addition, as planned, the project has obtained the first tranche
of private matched funding for the period from 1 April 2023 from
its existing private sector participants (including a contribution
of GBP1 million from Velocys). Velocys has appointed a leading
global investment bank to assist in obtaining the required
remaining matched funding from private sector investors to be in
place in the last quarter of 2023 (pursuant to the terms of the
grant funding).
In addition, the Group secured a separate grant of GBP2.5
million, also from the DfT's Advanced Fuels Fund, which offered a
specific funding allocation for the development of e-fuels projects
(those whose energy input is derived not from the carbon feedstock,
which is carbon dioxide, but rather from renewable electricity via
hydrogen). This grant was awarded to Velocys to assemble the
technology package for an e-fuels project in the UK, the e-Alto
power to liquids project, in collaboration with partners.
In the first quarter of 2023, Velocys announced the execution of
a master relationship agreement ("MRA") with Bechtel Limited
("Bechtel"), a leading worldwide provider of engineering,
construction and project management services, as SAF project
delivery partner to develop a centre of excellence model and
provide project engineering and other technical services to
Velocys' SAF project portfolio, thereby accelerating its
commercialisation strategy and significantly de-risking project
delivery by collaborating in development of a viable EPC execution
model for the Company's Reference Projects. Initially the
collaboration is focusing on Velocys' main Reference Projects - the
Altalto Project and the Bayou Fuels Project - together with the
recently announced e-Alto power-to-liquids project in the UK. The
MRA also covers other third-party projects that may be introduced
by either Bechtel or Velocys globally.
Under a separate continuing technical services agreement,
Bechtel is providing certain other technical services to support
the development of Velocys' SAF project portfolio. In particular,
Bechtel has commenced work on delivery of the Altalto Project FEED
phase advancing the Company towards revenue generation.
The Group is focused on accelerating delivery of Velocys'
technology and driving sustainable revenue opportunities.
Path to a dual listing
The Directors believe that a US Listing of the Company, in
addition to its existing admission to trading on AIM , will further
enhance the Company's reputation and increase global awareness of
the Company's proprietary technology. The Company already has a
significant presence in the US with its US office, manufacturing
and catalysis facilities in Ohio, engineering office in Houston as
well as the Bayou Fuels Project itself planned in Natchez
Mississippi. A US Listing will provide access to a large pool of
specialist investors and provide the potential for broader equity
research coverage and increased liquidity.
Whilst it cannot be guaranteed, the Directors are confident that
a US Listing can be achieved within 21 months from the issue of
Convertible Loan Notes to Carbon Direct Capital. The Directors
appreciate the significant sustained support they have received
from UK and other investors to date during a key stage of the
Company's growth and intend to maintain the Company's existing
admission of its Ordinary Shares to trading on the AIM market of
the London Stock Exchange for the foreseeable future alongside the
intended US Listing.
(b) Technology overview
The Group's technology is an embodiment of the Fischer-Tropsch
process which converts pure carbon monoxide and hydrogen synthesis
gas (syngas) via a catalytic chemical reaction into hydrocarbons
which are subsequently upgraded into fuels. The technology enables
an economic conversion of a wide range of low or negative- cost,
abundant sustainable feedstocks (including, but not limited to,
woody biomass residue or municipal solid waste that would otherwise
go to landfill or incineration) into high value sustainable fuels
such as SAF . These fuels qualify for decarbonisation credits in
both the United States (under the Renewable Fuels Standard) and in
the United Kingdom (under the Renewable Transport Fuels Obligation
) . These fuels have significant air quality advantages and reduce
the emission of particulates from aircraft by up to 90 per cent.
and lifecycle greenhouse gas emissions reductions by up to 70 per
cent., or over 150 per cent. when carbon capture and storage is
incorporated within the biorefinery.
The fuels are designed to be "drop-in", eliminating the need for
engine modification, and to be blended with conventional fossil
fuels, fully leveraging existing aircraft engines and logistics
infrastructure. They are approved by the American Society for
Testing and Materials for blending with Jet A-1 at up to 50 per
cent., so no adaptation is required to airport infrastructure or
aeroplane engines.
Although Fischer-Tropsch technology has been in existence for
decades, Velocys has developed a highly reactive catalyst and a
bespoke reactor to be used in an innovative way to manufacture
sustainable fuels. Velocys' proprietary Fischer-Tropsch technology
comprises microchannel Fischer-Tropsch reactor cores, containing a
highly active Fischer-Tropsch catalyst made by Velocys' proprietary
organic matrix combustion which are contained within a pressure
containment vessel/reactor. Velocys' technology provides the unique
combination of microchannel reactors and nanocatalyst technology
that allows an 8-10 fold increase in the speed of chemical
reactions compared with conventional Fischer-Tropsch technology,
and therefore much smaller reactors for any given volume of
throughput. Velocys' conversion pathway enables negative carbon
intensity fuels via CO(2) sequestration of between 30 per cent. and
40 per cent. of the feedstock carbon used, with a corresponding air
quality advantage via ultra-low Sulphur and a 2.5 particulate
matter.
The technology is developed in-house by Velocys and is protected
by a wide range of patents and trademarks across multiple key
jurisdictions. The catalysts are manufactured at commercial scale
by sub-contractors in the US under strict Velocys supervision. The
reactor cores have previously been manufactured by subcontractors
in the US using manufacturing equipment designed and owned by
Velocys, however the Company intends to use some of the proceeds
from the Fundraise to complete the capital investment in its Ohio
reactor core manufacturing facility which will improve the
automation and the capacity of this manufacturing by bringing final
assembly, testing and quality control in-house while using
qualified external contractors for standard components and
sub-assemblies. The new facility will have capacity to produce 48
cores per annum, sufficient for 12 reactors (the typical
requirement for a single biorefinery) which will be adequate to
meet projected production capacity needs until 2028. The internal
fit-out stage of the facility is now complete and is expected to
commence process validation in the last quarter of 2023 with live
production of reactor cores commencing in 2024.
(c) Market overview
The market for SAF is growing rapidly as airlines and
governments around the world are seeking to reduce the carbon
footprint of air travel. Commercial aviation is responsible for
approximately 13 per cent. of transportation greenhouse gas ("GHG")
emissions. With the advent of government mandates requiring the use
of SAF, the aviation industry seeks to reduce its GHG emissions
significantly, decoupling airline growth from carbon growth.
Purchasing fuel is the primary operating cost for airlines. SAF
represent s a significant global opportunity, with the value of
decarbonisation far exceeding the value of the fuel where there is
appropriate policy support for SAF. The International Air Transport
Association ("IATA") has committed to net-zero carbon emissions by
2050, requiring 450 billion litres of SAF to meet these net-zero
commitments. According to a report by the International Energy
Agency, the demand for SAF is expected to grow from less than 0.1
per cent. of total aviation fuel consumption in 2020 to around 10
per cent. by 2030. This represents a significant opportunity for
companies involved in the production, distribution and sale of SAF
as supply is extremely limited - current annual production is
approximately 100 million litres. Electric and hydrogen fuel
solutions are not considered current or short-to-medium term viable
solutions for long haul flights. SAF is a "drop-in" fuel that
requires no modifications to engines or infrastructure and can
still meet international specifications i.e., ASTM D7566 - a
provision under D7566 which allows any fuel meeting the
specifications to be reidentified as a conventional fuel. With this
inclusion, any SAF can be seamlessly integrated into the fuel
delivery infrastructure without the need for separate tracking or
regulatory approval, so providing the most viable option to help
achieve the net-zero commitments by 2050.
The Directors believe that the inevitable scale up in production
of SAF and the growing number of government mandates will make the
use of SAF widespread. The US has very competitive carbon
incentives through its existing Federal Renewable Fuel Standard
("RFS") and the Low Carbon Fuels Standard ("LCFS") in California.
The landmark Inflation Reduction Act of 2022 was passed by the US
Congress in relation to key legislation tackling climate change in
August 2022, allocating approximately $369 billion to reducing GHG
emissions and incentivises expanded production and use of domestic
clean energy. In the UK, the Government set out its Net Zero
Strategy in 2021 for an economy-wide plan to achieve Net Zero by
2050. As part of this ambition, in order to decarbonise the
aviation sector, in 2022 the UK Government's DfT set out its Jet
Zero strategy setting out a framework for securing a more
sustainable aviation industry with a target of at least 10 per
cent. SAF blended into the jet fuel mix by 2030. To help deliver
this, the Government has an ambition for a minimum of five
commercial-scale SAF plants to be in construction in the UK by
2025. This is being supported by the GBP165 million Advanced Fuels
Fund, from which Velocys is the largest recipient of grant funding.
This builds significantly on the previous 2021 Green Fuels Green
Skies grant initiative (of which Velocys was a recipient) which
made available GBP15 million in grant awards and demonstrates the
increasing support of the DfT.
On the 30 March the UK Government published its consultation
paper, Pathway to net zero aviation: developing the UK sustainable
aviation fuel mandate, which contains a number of proposals aimed
at supporting and financing the development of the sustainable
aviation fuel (" SAF ") industry. The Government has confirmed its
desire to establish the UK as a global leader in the development,
production and use of SAF by creating secure and growing SAF
demand, kickstarting a domestic SAF industry and working in
partnership with industry and investors to build long term supply.
The consultation comes amid growing support for decarbonisation and
further supports the UK Government's ambition of reaching net zero
by 2050 and its Jet Zero strategy. The proposed SAF mandate offers
a guaranteed level of demand and creates a long-term requirement to
supply SAF, provides incentives to SAF producers in the form of
tradeable certificates and signals the vital role SAF will play in
the future of UK aviation. The tradable certificates are intended
to close the gap between the cost of jetfuel and the cost of SAF,
with additional certificates awarded in proportion to avoided
carbon dioxide emissions.
IATA's net-zero carbon emissions commitment, aligns with the
Paris Agreement for global warming to not exceed 1.5degc. The EU
has proposed to set SAF blending mandates via the ReFuelEU proposal
published in July 2021. The Directors believe that these would
likely be set at 2 per cent. by 2025, 5 per cent. by 2030 and 32
per cent. by 2040. The International Civil Aviation Organisation
has introduced Carbon Offsetting and Reduction Scheme for
International Aviation as a global mandate for decarbonisation of
aviation and the Japanese Government has backed ventures launched
to progress commercial scale SAF production.
The Directors believe that Velocys' conversion pathway offers a
number of specific advantages. The Fischer-Tropsch Synthesised
Paraffinic Kerosene route is the most established of the seven
approved technical pathways under ASTM D7566, which allows the
flexible use of large-volume, low-cost sustainable feedstocks (such
as woody biomass residue and municipal solid waste) and generates
clean burning, low carbon sustainable fuel s. Velocys' standardised
solution can ultimately also lead to a reduced cost of capital for
clients when eligible for non-recourse project finance and can lead
to sustainable local production and distribution of fuel, resulting
in increased self-sufficiency and reduced reliance on fuel imports
for the host country. Multiplate pilot demonstrations have been
conducted in various global locations by 2015, including Brazil,
Austria (in 2010) and Japan.
Expected demand for SAF in Europe and the US, based on the EU's
latest proposals and current incentives in the US, is expected to
reach 3.7 billion litres per year by 2025, equivalent to 2 per
cent. of global jet fuel demand and the equivalent of the output
from 28 reference plants. By 2030, demand for SAF is expected to
rise to 10.3 billion litres per year, equivalent to 5 per cent. of
global jet fuel supply and the equivalent of the output from 78
reference plants. By 2040, demand for SAF is expected to rise
further to 77.6 billion litres per year, equivalent to 32 per cent.
of global jet fuel supply and the equivalent of the output from 586
reference plants.
Global SAF production was estimated to reach 0.3 to 0.45 billion
litres in 2022, an increase on output of 0.1 billion litres in
2021. This has increased continually since 2019 (0.025 billion
litres), with SAF output having climbed to 0.0625 billion litres in
2020. This mirrors an expected increase in global jet fuel demand,
which is anticipated to grow from 457 billion litres in 2025 to a
peak of 540 billion litres by 2045 (increasing by a rate of
approximately 8-20 billion litres every 5 years), before dropping
to 492 billion litres by 2050. Over the same period, the mandate
for SAF is expected to increase from 4 billion litres in 2025 to
166 billion litres by 2050. Predictions for 2030 place Europe and
the US as accounting for 40 per cent. combined of global jet fuel
demand.
Velocys' ambition is to capture 5 to 7 per cent. of the
long-term market share of the demand this will create for proven
SAF technology. The Group has an active and growing pipeline of
clients and projects. In 2025, the Directors expect that one of the
Group's clients will be in construction and three of the Group's
clients will be at the FEED phase. At this stage, the Group is
aiming to have a total design capacity of 230 million litres per
year, equivalent to 6 per cent. of the expected demand for SAF. By
2030, the Directors reasonably anticipate that 6 plants will have
been completed by the Group's clients, delivering a capacity to
meet 15 per cent. of the expected demand for SAF. By 2040, the
Directors currently forecast that up to 45 plants will have been
completed by the Group's clients with capacity to produce between
3.5 and 5 billion litres, equivalent to between 5 per cent. and 7
per cent. of the expected demand for SAF.
(d) Business model
The Group has a hybrid, capital-light business model, focusing
on delivering Fischer-Tropsch reactors and catalysts to global
clients under site-licence agreements and providing engineering
services over the course of the 25 year expected lifetime of the
assets. Some of Velocys' clients require the Fischer-Tropsch
Technology Island only ("FTI"). However, Velocys' core offering
provides its clients with a full end-to-end solution for the
conversion of solid sustainable feedstocks to SAF via its so called
"Integrated Technology Package" ("ITP"). The Group's two
biorefinery Reference Projects are designed to accelerate the
end-to-end technology adoption as well as providing a source of
future revenue to the Group. To date, the Group's technology is
already commercially referenced through its contracts with a
consortium including Toyo in Japan. The Group's FTI has been
further demonstrated at commercial scale by the ENVIA plant in
Oklahoma during 2017 and 2018, with integrated commercial
operations and pilot trial upgrade for fuel and diesel product
completed in 2019.
The Group's revenue from its ITP solution comprises a
combination of upfront fees and recurring fees as follows:
-
Integrated Technology Package
(ITP)
Technology Commissioning Upfront * Licence fees commence at FEED through completion
licence fees and start-up fees
Reactor sales Optimisation
Engineering fees * Initial reactor and catalyst payments upon
fees construction through completion
* Engineering fees payable throughout construction and
commissioning
----------------- -------------- ----------
Catalyst sales and replacement Recurring
Decarbonisation royalties fees * Catalyst sales and service fees every two years over
plant life
* Royalties based on avoided carbon from fuels
production
---------- ------------------------------------------------------------
In 2021, Velocys recognised revenue of GBP8.3 million following
the delivery of reactors and catalysts to prior years clients.
The Group is building a growing pipeline of international
clients that are developing biorefineries and has sufficient
production capacity to meet projected orders until 2028. This
includes developing its existing relationships including with Toyo
in Japan and pursuing new project opportunities. In 2021 Velocys
signed a collaboration agreement with Toyo to start development of
their commercial scale biomass-to-jet fuel project along with other
renewable fuel opportunities. The Group is also undertaking a
number of pre-feasibility studies with potential plant owners to
ascertain the potential for projects to move into pre-detailed
engineering and project development.
Further information on the Group's existing projects is provided
below.
Revenue opportunity
Velocys offers a de-risked solution having undertaken multiple
demonstrations in various global locations with the flexibility of
various feedstocks from woodchips, residual waste, hydrogen and
biomethane. With the ability to enable negative carbon intensity
fuels via CO(2) sequestration of 30-40 per cent. of the feedstock
carbon, which also has the advantage of improved air quality with
ultra-low sulphur and 2.5 particulate matter, Velocys' standardised
solution accelerates the path to non-recourse project financing and
sustainable local production and distribution of synthetic fuels
and provides a significant opportunity for growth in a sustainable
fuel market with enormous unsatisfied demand particularly for
SAF.
The business model is established to provide both upfront and
recurring fees. The upfront fees consist of licence fee revenues
which commence at the FEED stage of projects and are payable in
instalments up to completion. Additional upfront fees are generated
through reactor sales and initial catalyst down payments at start
of project construction with final payments at completion along
with engineering services payable throughout construction and
commissioning of the plants and projects. The recurring revenues
are derived from catalyst sales and service fees which recur every
two years over the lifetime of the plant, in addition to royalties
based on avoided carbon fuels production earned where Velocys has
delivered early-stage project development as per the Reference
Projects.
The Directors believe there is significant opportunity to expand
its pipeline and contracts aided by increased reactor production
capacity from its new reactor core manufacturing facility in Ohio.
The below table provides illustrative examples of potential
revenues generated from varying types of client projects:
Project Type Reactors 10 Year N et 10 Year NPV(2)
C ashflow (1)
Small project and demonstration
plant Up to 6 $12m - $19m $9 - $13m
---------- ---------------- ----------------
Woody Biomass 12 - 20 $23m - $60m $16 - $39m
---------- ---------------- ----------------
Municipal Solid Waste 9 - 12 $17m - $37m $12 - $25m
---------- ---------------- ----------------
Reference Project 16 $97m $57m
---------- ---------------- ----------------
(1) 10-year net cashflow - net cashflow to Velocys from FEED
(Year 1) to year 6 (Year 10) of commercial production
(2) WACC 9.7 per cent.
Growth strategy
Velocys' ambition is to become a leading provider of advanced
SAF solutions to enable the decarbonisation of the aviation
industry by focusing on technology innovation. The Company's
strategy to achieving this is centred around accelerating its two
full scale biorefinery Reference Projects to generate revenues,
accelerate technology adoption and define a blueprint for future
clients.
By working with leading industry partners, the Company is
advancing its current Reference Projects towards commercialisation,
demonstrated by the Altalto Project entering its critical FEED
phase supported by the UK Governments' Advanced Fuels Fund grant
and the broad engineering collaboration with Bechtel. In the US,
the Bayou Fuels Project is also moving towards the FEED phase with
funding for project development capital expected to close during
the last quarter of 2023 following the appointment of a leading
global investment bank to source funds for the development phases
of both Reference Projects.
The Directors believe the growth strategy for the Group is
focused on strengthening its commercial development pipeline
concentrating on revenue producing opportunities delivering
valuable upfront services for clients and a wider reach on pipeline
opportunities from increased enquiries and paid studies. In order
to accelerate this capacity and pipeline, the new reactor core
manufacturing facility in Ohio is targeting production in 2024 with
an increased output capacity of 12 reactors per year. Additionally,
the Company is looking to develop and grow its pipeline through
significant investment in people, processes and systems. Velocys is
looking to scale the organisation, by undertaking a selective
recruitment process to gradually increase headcount from
approximately 40 full time employees to approximately 100 full time
employees over the next 12 to 18 months in line with increased
contracted client demands, with a focus on engineering capacity in
order to propel the Company towards sustainable revenue
generation.
Velocys' growth strategy can be summarised as being to:
-- strengthen its business development function to grow its client pipeline;
-- invest in the scale-up of its reactor manufacturing capacity;
-- capitalise on strategic alliances with its technology
partners to further enhance the Group's standardised integrated
solution;
-- accelerate its collaborations with technology partners and to
outsource standardised activities to remain capital light;
-- target geographical markets where the regulatory environment
and/or pricing economies create the highest value opportunities for
its clients; and
-- expand engineering and technical resources to support its
clients' needs from feasibility stage to detailed engineering.
The Directors believe this growth strategy will enable the Group
to have 6 clients with completed plants by 2030 with capacity to
reach up to 15 per cent. of expected SAF demand with potential
additional significant growth projected beyond this - the Directors
currently forecast that up to 45 plants may be completed by the
Group's clients by 2040 using Velocys' technology.
(e) Bayou Fuels Project in Mississippi, US: reference project
Overview
In October 2017, the Group signed a site option agreement with
Adams County in the State of Mississippi for a biorefinery facility
to be located in Natchez, Mississippi and secured total site
incentives of approximately $60 million. The Bayou Fuels Project is
a planned cellulosic biofuels plant enabling the production of
carbon negative fuel through the use of biogenic feedstock,
renewable power, and carbon sequestration. The biorefinery, when it
enters production planned for 2028, will convert 3,000 tons/day of
woody biomass forestry residues into 36 million gallons/year
(nameplate) of renewable transportation fuels, predominantly SAF,
with a negative carbon intensity using renewable energy derived
from sustainable biomass power.
In October 2022, the Group announced it had re-optimised its
Bayou Fuels facility for maximum decarbonisation to a negative
carbon intensity of -375g CO(2) e/MJ (previously -144g CO(2) e/MJ);
abating the carbon emissions from the equivalent of 1.1 million
return economy trips from San Francisco to London per year. This
optimisation marks a significant improvement in the negative carbon
intensity score of the plant with the potential to increase future
revenue for the Bayou Fuels Project and enhance the attractiveness
of the project for third party project funding.
Critical legislative developments in the US have taken place
recently benefiting the Bayou Fuels Project, most significantly the
US Inflation Reduction Act of 2022, signed into law on 16 August
2022, which allocates $369 billion to reducing greenhouse gas
emissions and incentivises expanded production and use of domestic
clean energy. A variety of SAF tax credits are an integral part of
the Act, together with other incentives and mechanisms to
accelerate the deployment of advanced fuel technologies generating
non-fossil fuels with a significantly reduced carbon intensity. The
biofuels that will be produced will adhere to both the US RFS and
the LCFS and earn additional incentives through the associated
Renewable Identification Number and LCFS credits. On 19 November
2021 the US House of Representatives passed a bill that provides a
SAF Blenders Tax Credit, which is worth $1.75/gallon for the SAF
produced from the Bayou Fuels Project. The US administration has
recently announced additional policy incentives to accelerate the
production of SAF, with up to $5 per gallon by way of SAF Producer
Tax Credit indexed to carbon intensity, available from 2027, which
would replace the SAF Blenders Tax Credit.
Following a competitive RFP process, the Group has appointed a
leading global investment bank to assist in securing the necessary
development capital from strategic partners for the project. The
Group expects one or more clients to finance and own the
construction of the Bayou Fuels Project with the terms of the
financing determining Velocys' interests in the project
post-financing. Potential scenarios include, inter alia, Velocys
retaining a minority interest in the project or converting its
interest into a "decarbonisation royalty" or receiving a
development fee. Completion of this capital raise is expected in
the last quarter of 2023.
Offtake agreements
Multi-year offtake contracts have been agreed, covering 100 per
cent. of the SAF expected to be produced by the biorefinery plant,
underwriting $3.1 billion in revenue and avoiding 18.7 million tons
of CO(2) .
(i) Offtake agreement with Southwest Airlines
On 10 November 2021, the Group entered into its first offtake
agreement for the SAF to be produced by the Bayou Fuels Project
with Southwest Airlines, America's largest domestic airline. The
agreement covers the purchase by Southwest Airlines of an expected
219 million gallons of SAF at a fixed price and floor price for
greenhouse gas credits, over a fifteen-year term from 2028, when
the biorefinery is scheduled to begin commercial delivery of fuel.
After blending, this is expected to produce approximately 575
million gallons of net zero SAF.
This offtake agreement covers two thirds of the project
facility's planned production and de-risks up to $2 billion
revenues over the life of the contract. Each gallon of SAF
generated by the project is expected to generate tradable
greenhouse gas credits for which Southwest Airlines guarantees a
minimum price payable to the project (included in the fuel fixed
price), de-risking a significant proportion of the revenue stream
to the project. The project may additionally benefit from the value
of greenhouse gas credits if sold above the minimum price
underwritten by Southwest Airlines.
Southwest Airlines and Velocys have also, as part of the offtake
agreement, agreed to a long-term strategic alliance for future
US-based biorefineries in which Velocys may be involved with the
right for Southwest Airlines to purchase significant volumes of SAF
from such facilities.
The offtake agreement is subject to certain customary conditions
precedent including completion of satisfactory financing for the
project's front-end engineering and design phase and certain
construction milestones, eligibility for greenhouse gas credits as
well as the enactment of the proposed SAFs tax credit
legislation.
(ii) Offtake memorandum of understanding with IAG
On 10 November 2021, the Group entered into a non-binding
memorandum of understanding for the offtake of SAF to be produced
at the project with IAG. This covers the purchase by IAG's
constituent airlines, which includes British Airways, Aer Lingus
and Iberia amongst others, of an expected 73 million gallons of
SAF, in aggregate, at a fixed price. After blending, this is
expected to produce the equivalent of approximately 192 million
gallons of net zero SAF during the term of the agreement, which
will last for ten years from the expected commencement date of
operation of the project in 2026. This represents one third of the
facility's planned annual output and complements the binding
offtake agreement for the remaining two thirds annual output
entered into on the same date with Southwest Airlines as described
above.
The intention of the parties is to convert the memorandum of
understanding, which includes all material terms for the offtake,
into a binding agreement as the project progresses. The memorandum
of understanding also includes an option for IAG to invest in the
Bayou Fuels Project development phases.
The fixed price fuel purchase agreement includes a price support
mechanism by IAG for the greenhouse gas credits associated with the
SAF production. As a result, the agreement is expected to generate
revenues of over $800 million to the project and achieve an
estimated total of 2.2 million tonnes of avoided CO(2) over the
term of the offtake.
Future milestones
The Company is intending to raise development capital for the
Bayou Fuels Project closing in the third quarter of 2023 to advance
from FEED to FID stage. A leading global investment bank has been
appointed as financial advisor to the project. Initial engineering
for the project has commenced, with detailed engineering expected
to commence in 2024. Design capacity for the site is expected to be
108,000 tonnes per year of SAF generating over 1.3 million tonnes
per year of CO(2) avoided with ultra-low negative carbon intensity,
with the aim to enter production in 2028 and increase this figure
to 1.8 million tonnes per year of avoided CO(2) . Levee
construction is anticipated to be finalised in the last quarter of
2023, a critical milestone for insurance and de-risking of the
site. Signature of the final commercial agreements for the project,
FID and financial close is expected in 2025, following which plant
construction is expected to occur during 2025 and 2026.
Construction is targeted to be completed by 2027 followed by plant
commissioning and start up with full scale commercial operation
targeted to commence in 2028.
(f) Altalto Project in Immingham, UK: reference project
Overview
The Group's Altalto Project, which is administered through a
joint development agreement between the Company and British
Airways, will take household and commercial waste which, after
recyclates have been removed, would be destined for landfill or
incineration, and instead converts that waste into clean-burning
SAF and naphtha.
The Group has completed feasibility work in relation to site
engineering, geotechnical survey and integration of carbon
sequestration of biogenic CO(2) in preparation for the connection
of the Altalto plant, when built, into a new Carbon Capture and
Storage cluster, which is being developed by a consortium.
In March 2022, Altalto Immingham Ltd (a subsidiary of the Group)
sold its 100 per cent. interest in Rula Developments (Immingham)
Limited ("RDIL"), which owns the site for the Altalto Project, to
Foresight Group LLP for GBP9.75 million, with a call option for
Altalto to repurchase RDIL within three years. Foresight has a
proven track record and history of investing in energy transition
infrastructure and also has an option to invest up to GBP100
million in the future project construction phase. Following the
sale, the Project has retained the right to access the land for
maintenance and pre-development activities associated with its
existing planning permission.
As announced on 12 December 2022, the Group secured a grant from
the DfT under the Advanced Fuels Fund up to a maximum of GBP27
million for the Altalto Project. The Advanced Fuels Fund
prioritises first-of-a-kind commercial scale SAF plants that
require additional support to become ready for investment and
construction. The fund also aims to leverage private investment,
both by supporting projects to reach an "investor ready" status and
by prioritising projects that have secured matched funding. The
grant funding, which will be distributed over the grant period
through to March 2025 will support Altalto to deliver the FEED
stage of the project, which will incorporate the integrated
technology packages of the licensors (including Velocys) and
develop the basis for the Engineering, Procurement and Construction
("EPC") contract. The Group has obtained letters of intent from a
number of existing and new potential partners for the
private-sector matched funding requirement with the first tranche
of funding due to be in place during the first half of 2023.
Velocys has previously received grants for the Altalto project
of GBP1.7 million from the DfT's Green Fuels, Green Skies
competition and a series of grants totalling GBP934,000 from the
Future Fuels for Flight and Freight competition, the predecessor to
Green Fuels, Green Skies.
Further to legislative developments in the US, the UK
legislation has also progressed, with the UK Government's Net Zero
Strategy including developing a SAF mandate to enable delivery of
10 per cent. SAF by 2030. The UK DfT also announced its Jet Zero
Strategy in July 2022, setting out the Government's approach for
achieving net zero aviation by 2050. This includes an ambition for
a minimum of five commercial-scale SAF plants to be under
construction in the UK by 2025 which is being supported by the
GBP165 million Advanced Fuels Fund. Nevertheless, the continued
lack of finalised UK policy support also poses challenges for the
Altalto Project. The Company looks forward to the conclusion of the
UK Government's consultation process and finalised plans for the
policy support necessary to kick-start the UK based SAF
industry.
The Group has agreed with British Airways to further extend the
terms of both the Altalto Project's joint development agreement and
the option agreement which allows British Airways to acquire 50 per
cent. of Altalto Limited by one year to 31 March 2024
Velocys' cash contribution to the Altalto Project over two years
from April 2023 is not expected to exceed GBP8 million, with
Velocys intending to achieve a net zero contribution.
Future milestones
A leading global investment bank has been appointed raise the
Altalto Project matched funding (alongside the DfT grant).
Completion of this development capital raise is expected during the
last quarter of 2023. The FEED phase is underway, with construction
expected to commence in the second half of 2025, following which
full scale commercial operation is anticipated in the second half
of 2028. Current expectations for the site include a design
capacity of 60,000 tonnes per year, with 350,000 tonnes per year of
CO(2) avoided via the carbon capture system. The Directors believe
that fuel produced from the Altalto Project could be worth over
GBP3 per litre if rewarded in proportion to CO(2) reduction, plus
any additional price support that may be provided.
(g) Other revenue generating clients and pipeline
The Company continues to provide services and support to Toyo
Engineering Corporation in Japan under the Collaboration Agreement
signed in late 2021 as progress continues on the NEDO projects to
proceed towards the FEED phase in 2024. In addition, the business
development pipeline continues to grow, with a number of
feasibility studies underway with both biorefinery and advanced
power-to-liquid developers, as well as a significant increase in
enquiries for potential projects. Velocys expects to move forward
with a number of new clients globally through 2023.
Separate to the Altalto Immingham Project grant, the Group has
secured a grant of GBP2.5 million, also from the DfT's Advanced
Fuels Fund for the development of an e-fuels projects (those where
energy input is derived not from carbon feedstock, which is carbon
dioxide, but rather from renewable electricity via hydrogen). This
e-fuels grant has been awarded to Velocys to assemble the
technology package for an e-fuels project in the UK, in
collaboration with a number of new and existing partners.
3. Current Trading
Whilst Velocys continues to progress its Reference Projects with
its partners and develop its longer-term pipeline, the Company is
focused on near term revenue generation and delivering sustainable
shareholder value. Velocys has made substantial progress over the
last year on both projects and has achieved a number of key
milestones and objectives which place the Company in a strong
position to progress its Reference Projects through to key
valuation inflection points and build its commercial pipeline.
The Company announced its preliminary unaudited results for the
year ended 31 December 2022 today 18 May 2023. As of 31 December
2022, Velocys had a cash balance of GBP13.4 million (2021: GBP25.5
million). Preliminary unaudited revenues are approximately GBP0. 2
million (2021: GBP8.3 million) and a net loss of GBP13.2 million
(2021: GBP8.4 million). As of 30 April 2023, the Company had a cash
balance of GBP8.1 million (including GBP0.6 million of restricted
cash).
Annual revenues are expected to remain uneven in the short-term
due to the growing but concentrated number of SAF projects in
development whilst the market becomes more established. Revenue
generated in 2021 was in respect of engineering feasibility
services provided during the year whereas the 2021 revenue was
mainly the conclusion of a contract with our first major commercial
client, which commenced in 2017, for the supply of reactors and
catalyst, and associated licensing fees to operate the technology.
The Company satisfied the performance obligations within the
contract in June 2021 following expiry of all contractual
obligations and therefore recognised the revenue and associated
cost of goods in 2021.
4. IP Portfolio
Velocys has an extensive and actively managed intellectual
property portfolio of over 200 granted patents, 90 pending patents
and various trademarks. Substantive IP is important for SAF as a
relatively new technology and the development of new SAF
feedstocks, production processes and applications requires
significant R&D investment. It is essential for creating a
competitive market for SAF and encourages continued innovation and
provides a measure of security and stability for investment. It
also underpins Velocys' licensing agreements, joint ventures and
other commercial arrangements that helps to expand the market for
SAF and increase its adoption.
5. Use of Proceeds
The Group is focused on accelerating delivery of Velocys'
technology and driving revenue opportunities through the economic
production of SAF with the mission of facilitating decarbonisation
of the aviation industry.
The Directors intend to use the net proceeds from the Placing,
the Retail Offer and the Open Offer as follows:
o GBP5 million - Organisation costs including project delivery
and business development;
o GBP1 million - engineering scale-up with investment in
engineering resource; and
o Balance - working capital requirements to invest in achieving
supply chain resilience and to cover timeline of grant
receipts.
In the event of the Minimum Amount being raised, the net
proceeds of the issuance of the Convertible Loan Notes to Carbon
Direct Capital and the issuance of further Convertible Loan Notes
and/or Ordinary Shares to investors other than Carbon Direct
Capital will be used primarily for:
o GBP12 million - scaling-up of the organisation and corporate
costs including increasing labour from approximately 40 full time
employees to approximately 100 full time employees gradually over
the next 12 to 18 months in line with client and project demand in
order to accelerate the capability of the Company to deliver its
technology to its clients at scale;
o GBP7 million - completion of capital investment in the Ohio
reactor core manufacturing facility including production start-up
and catalysis upgrades;
o GBP3 million - funding for US Listing costs or interest
payments due on the Convertible Loan Notes in the event no US
Listing occurs during the 21-month period from issue of the
Convertible Loan Notes;
o GBP2 million - supporting performance guarantees for the
Company's proprietary Fischer-Tropsch technology to be delivered to
client projects;
o GBP1 million - working capital requirements, build-up of
reactor inventory at the Ohio manufacturing facility and to manage
timing of payments and grant receipts; and
o additional funds raised up to the Maximum Amount, will be used
to drive further commercialisation and balance sheet strength ahead
of a potential US listing.
6. Principal terms of the Convertible Loan Notes.
In addition to the Placing, the Retail Offer and the Open Offer,
the Company proposes raising a minimum of $15 million
(approximately GBP12 million), before expenses, by way of the
proposed, conditional, non-pre-emptive issue to Carbon Direct
Capital of Convertible Loan Notes, convertible into Ordinary Shares
at the Issue Price. The Company intends to issue further
Convertible Loan Notes and/or new Ordinary Shares to investors
other than Carbon Direct Capital. The terms of the Convertible Loan
Notes are governed by the Convertible Loan Note Instrument.
Pursuant to the Commitment Letter, the issue of Convertible Loan
Notes to Carbon Direct Capital is conditional, inter-alia, upon the
passing of the Resolutions at the General Meeting. If this
condition is not satisfied, the Convertible Loan Notes will not be
issued to Carbon Direct Capital. In addition to (i) the passing of
the Resolutions, the issue of the Convertible Loan Notes is also
conditional upon (ii) the Company raising or having received
legally binding commitments to raise at least $40 million
(approximately GBP32 million) less the amount subscribed for by
Carbon Direct Capital in aggregate, before expenses, through the
Fundraise from other investors other than Carbon Direct Capital
(the "Minimum Amount") by no later than 30 September 2023 (the "CLN
Long Stop Date") and (iii) there being no material breach of
certain of the representations and warranties of the Company as
given in the Commitment Letter between the date of the Commitment
Letter and the date of issuance of the Convertible Loan Notes to
Carbon Direct Capital. The Company and Carbon Direct Capital may
agree to extend the CLN Long Stop Date to no later than 31 December
2023.
The key terms of the Convertible Loan Note Instrument are:
-- each of the CLN Investors has the right to convert all or
part of its Convertible Loan Notes into fully-paid Ordinary Shares
at any time;
-- unless earlier converted into Ordinary Shares or redeemed,
the Convertible Loan Notes shall be automatically converted into
fully-paid Ordinary Shares conditional on, and immediately prior
to, the commencement of trading on a US Listing;
-- unless already converted into Ordinary Shares or redeemed,
the outstanding amounts under the Convertible Loan Notes (being the
principal amounts of the Convertible Loan Notes plus accrued
interest) shall be redeemed in cash by the Company or converted in
full or in part at the election of the relevant CLN Investor on the
date that falls 36 months following their issue (the " Final
Maturity Date ");
-- if any of the Company or certain members of the Group suffers
an insolvency event, if a change of control transaction has
occurred, or if the admission to trading on AIM of the Ordinary
Shares is cancelled (save in connection with a US Listing or other
listing of the Company's securities on an investment exchange), the
outstanding Convertible Loan Notes shall, at the election of the
relevant CLN Investor, be redeemed in cash by the Company at 1.5
times the outstanding amount or be converted into Ordinary
Shares;
-- if a lender to any member of the Group takes any step to
enforce any security granted to that lender by any member of the
Group as a result of an event of default by any member of the Group
where the indebtedness is at least GBP100,000 in the aggregate, the
relevant CLN Investor shall have the right to elect for its
outstanding Convertible Loan Notes to be redeemed in cash by the
Company;
-- notwithstanding any other provision in the Convertible Loan
Note Instrument, in the event that a conversion into Ordinary
Shares would result in a CLN Investor (together with any persons
acting in concert with it) holding 30 per cent. or more of the
voting rights of the Company, the relevant CLN Investor shall be
entitled to convert such number of Convertible Loan Notes as would
cause it (together with any person acting in concert with it) to
hold up to 29.99 per cent. of the voting rights of the Company but
shall not in any circumstances be obliged to make a conversion in
respect of those Convertible Loan Notes that would result in it
(together with any person acting in concert with it) holding 30 per
cent. or more of the voting rights of the Company (the "Excess
Notes"), and if not converted at the election of the relevant CLN
Investor, the Excess Notes will remain outstanding until the date
on which the Company obtains a Rule 9 waiver from the Panel on
Takeovers and Mergers, following which the Excess Notes shall be
converted or redeemed in cash by the Company if agreed;
-- on conversion of the Convertible Loan Notes to Ordinary
Shares, such number of fully-paid Ordinary Shares shall be issued
to the CLN Investors that equals the outstanding principal amount
of the notes plus any applicable interest (converted into Sterling
at the time of conversion) at a price of 2.5 pence per Ordinary
Share or, if lower, the lowest price per Ordinary Share at which
the Company issues Ordinary Shares to a Shareholder or investor in
connection with an equity fundraising by way of the issue of new
Ordinary Shares in the Company, or the conversion or exercise price
for any further issue of convertible loan notes or issues of
warrants, if any, which is completed after the date of the issuance
of the Convertible Loan Notes but prior to the date of conversion
of the Convertible Loan Notes;
-- the Convertible Loan Notes will not bear interest if the US
Listing is completed within 21 months of the date of issuance of
the Convertible Loan Notes and the Convertible Loan Notes are
converted into fully-paid Ordinary Shares on such US Listing (to
the extent not already redeemed or converted). The Convertible Loan
Notes bear interest at an annualised interest rate of 12.5 per
cent. from the date of issuance of the Convertible Loan Notes until
the Final Maturity Date or earlier conversion or redemption which
shall accrue in varying monthly coupons after the period of 21
months from the date of issue of the Convertible Loan Notes;
-- while any Convertible Loan Notes remain outstanding, the
Company shall not pay any dividends or make any repurchases of its
Ordinary Shares or other class of shares; and
-- the Convertible Loan Notes are not transferable, save to affiliates.
The maximum number of Ordinary Shares that may be issued on
conversion of the Convertible Loan Notes that are proposed to be
issued to Carbon Direct Capital and to other investors (assuming
the balance of the Maximum Amount, less funds raised pursuant to
the Placing,, is subscribed for in Convertible Loan Notes and
further assuming that all Convertible Loan Notes are converted on
the Final Maturity Date together with all accrued interest at a
conversion price of 2.5 pence and on the basis of a currency
exchange rate of GBP/USD 1.2487, being the Bloomberg rate on 17 May
2023 (the last practicable date prior to the publication of this
document) is 1,662,351,597 Ordinary Shares. The Ordinary Shares
issued on a conversion of the Convertible Loan Notes will, when
issued, rank pari passu in all respects with the other Ordinary
Shares then in issue, including all rights to all dividends and
other distributions declared, made or paid thereafter.
The Convertible Loan Notes will not be admitted to trading on
AIM or any other investment exchange.
The Commitment Letter contains warranties from the Company in
favour of Carbon Direct Capital in relation to (amongst other
things) the Company and its business and Carbon Direct Capital's
commitment to acquire Convertible Loan Notes is conditional on
there having been no material breach of certain of the warranties
by the Company prior to issuance of the Convertible Loan Notes to
Carbon Direct Capital.
7. Principal terms of the Placing
The Company is conducting a conditional, non-pre-emptive placing
and retail offer to raise approximately GBP6 million at the Issue
Price. The Placing Shares a will be placed by Panmure Gordon and
Shore Capital as agents for the Company and pursuant to the Placing
Agreement, with institutional and other professional investors.
The Issue Price represents a discount of 26.9 per cent. to the
closing mid-market price of the Ordinary Shares as at 17 May 2023
of 3.42 pence per Ordinary Share. The Placing Shares will, when
issued, be credited as fully paid and will rank pari passu in all
respects with the other Ordinary Shares then in issue, including
all rights to all dividends and other distributions declared, made
or paid following Admission .
The Placing is conditional upon (amongst other things):
(a) the passing of the Resolutions relating to the Placing, the
Retail Offer and the Open Offer at the General Meeting;
(b) the Company allotting, subject only to Admission, the
Placing Shares in accordance with the Placing Agreement;
(c) none of the warranties given by the Company in the Placing
Agreement being untrue, inaccurate or misleading to an extent which
would be material as at the date of the Placing Agreement or at any
time between the date of the Placing Agreement and Admission;
(d) Admission having occurred by no later than 8.00 a.m. on 9
June 2023 or such later date as the Company and the Joint
Bookrunners may agree, but in any event not later than the Placing
Long Stop Date; and
(e) the Company having complied with its obligations under the Placing Agreement.
The Placing Agreement contains warranties from the Company in
favour of Panmure Gordon and Shore Capital in relation to (amongst
other things) the Company and its business. In addition, the
Company has agreed to indemnify Panmure Gordon and Shore Capital in
relation to certain liabilities it may incur in undertaking the
Placing. Panmure Gordon and Shore Capital have the right to
terminate the Placing Agreement in certain circumstances prior to
Admission, in particular, it may terminate in the event that there
has been a material breach of any of the warranties or for force
majeure .
Application will be made for the Placing Shares to be admitted
to trading on AIM. It is expected that trading in Placing Shares
will commence at 8.00 a.m. on or around 9 June 2023.
It is expected that certain Directors and senior management in
the Company will subscribe for New Ordinary Shares through the
Placing for an aggregate amount of approximately GBP75,000. Further
details will be announced as appropriate in due course.
8. Principal terms of the Open Offer
The Company considers it important that, where reasonably
practicable, Eligible Shareholders have an opportunity to
participate in its equity fundraisings. Accordingly, the Company
intends to raise up to approximately GBP2 million (before expenses)
by way of the Open Offer.
The Open Offer has been structured such that the Maximum Amount
that can be raised by the Company under the Retail Offer and the
Open Offer will not exceed the sterling equivalent of EUR 8
million. The limit of approximately GBP2 million for the Retail
Offer and the Open Offer has been set to allow existing Eligible
Shareholders to participate in the Fundraise, taking into account
the dilution of Eligible Shareholders not able to participate in
respect of the Placing and the capital needs of the Company. The
maximum aggregate limit of the Retail Offer and the Open Offer also
ensures that the Company is not required to produce an approved
prospectus pursuant to section 85 of FSMA. The issue of a
prospectus would considerably increase the costs of the Fundraise
and it would take much longer to complete, as any such prospectus
would require the prior approval of the FCA.
On and subject to the terms and conditions of the Open Offer,
the Company invites Eligible Shareholders, being only those
Shareholders who are resident in the United Kingdom and who are not
Sanctioned Shareholders on the Ex-Entitlement Date, to apply for
their Basic Entitlement of Open Offer Shares at the Issue Price.
Each Eligible Shareholder's Basic Entitlement has been calculated
on th e basis of 1 Open Offer Share for every 18 Existing Ordinary
Shares held at the Record Date.
Eligible Shareholders are also invited to apply for additional
Open Offer Shares in accordance with the Excess Entitlement. Any
Open Offer Shares not issued to an Eligible Shareholder pursuant to
their Basic Entitlement will be apportioned between those Eligible
Shareholders who have applied for the Excess Entitlement at the
sole discretion of the Board, provided that no Eligible Shareholder
shall be required to subscribe for more Open Offer Shares than they
have specified on the Application Form or through CREST.
The Open Offer is conditional upon (amongst other things):
(a) the passing of the Resolutions relating to the Placing, the
Retail Offer and the Open Offer at the General Meeting;
(b) the Placing Agreement becoming unconditional and the Placing
Agreement not having been terminated in accordance with its terms;
and
(c) Admission occurring on or before 9 June 2023 (or such later
date as Panmure Gordon, Shore Capital and the Company may agree,
not being later than 23 June 2023).
The Open Offer Shares have not been and are not intended to be
registered or qualified for sale in any jurisdiction other than the
United Kingdom. Accordingly, unless otherwise determined by the
Company and effected by the Company in a lawful manner, the
Application Form will not be sent to existing Shareholders with
registered addresses in any jurisdiction other than the United
Kingdom since to do so would require compliance with the relevant
securities laws of that jurisdiction. The Application Form will not
be sent to any Sanctioned Shareholders. Applications from any such
person will be deemed to be invalid. If an Application Form is
received by any Sanctioned Shareholder or any Shareholder whose
registered address is elsewhere but who is in fact a resident or
domiciled in a territory other than the United Kingdom, it should
not seek to take up its allocation.
The Circular contains the full terms and conditions of the Open
Offer.
9. Recommendation
The Directors consider that the Fundraise and the Resolutions
are in the best interests of the Company and its Shareholders as a
whole. The Company is reliant on the net proceeds of the Placing,
the Retail Offer and the Open Offer to meet its ongoing liquidity
requirements and to continue to implement its strategy. Funds
raised through the Placing, the Retail Offer and the Open Offer
will be used primarily to provide growth capital in preparation for
significant scale-up and working capital through expected key
valuation inflection points. The Company intends to use any further
funds raised in connection with the Fundraise (other than through
the Placing, the Retail Offer and the Open Offer) for the purposes
of driving the Company's technology delivery capability and to
provide balance sheet strength whilst continuing to build a revenue
generating pipeline. If the Resolutions are not passed by
Shareholders, the Fundraise will not proceed. In these
circumstances, the Directors will need to reconsider the Company's
strategy and the Company may need to seek alternative funding,
which may not be available on terms which are acceptable to the
Company or at all. Accordingly, the Directors unanimously recommend
that Shareholders vote in favour of the Resolutions, as they intend
to do in respect of their own legal and/or beneficial
shareholdings, amounting, in
aggregate, to 4,654,896 Ordinary Shares (representing
approximately 0.3 per cent. of the Ordinary Shares in the issue as
at the date of this announcement).
APPIX II
TERMS AND CONDITIONS OF THE PLACING
INTRODUCTION
IMPORTANT INFORMATION FOR PLACEES ONLY REGARDING THE
PLACING.
THIS ANNOUNCEMENT, INCLUDING THIS APPIX, AND THE INFORMATION IN
IT, IS RESTRICTED, AND IS NOT FOR PUBLICATION, RELEASE OR
DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR
INTO THE UNITED STATES, CANADA, AUSTRALIA, NEW ZEALAND, THE
REPUBLIC OF SOUTH AFRICA OR JAPAN ("THE EXCLUDED TERRITORIES") OR
ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION
WOULD BE UNLAWFUL.
IMPORTANT INFORMATION ON THE PLACING FOR INVITED PLACEES
ONLY.
THE PLACING SHARES THAT ARE THE SUBJECT OF THE PLACING ARE NOT
BEING OFFERED OR SOLD TO ANY PERSON IN THE EUROPEAN UNION OR THE
UK, OTHER THAN TO QUALIFIED INVESTORS, WHICH INCLUDES LEGAL
ENTITIES WHICH ARE REGULATED BY THE FCA OR ENTITIES WHICH ARE NOT
SO REGULATED WHOSE CORPORATE PURPOSE IS SOLELY TO INVEST IN
SECURITIES.
MEMBERS OF THE PUBLIC IN THE UK OR ELSEWHERE ARE NOT ELIGIBLE TO
TAKE PART IN THE PLACING. THIS ANNOUNCEMENT (INCLUDING THIS APPIX)
AND THE TERMS AND CONDITIONS SET OUT HEREIN ARE FOR INFORMATION
PURPOSES ONLY AND ARE DIRECTED ONLY AT: (A) PERSONS IN A MEMBER
STATE OF THE EUROPEAN ECONOMIC AREA WHO ARE QUALIFIED INVESTORS
(WITHIN THE MEANING OF THE PROSPECTUS REGULATION (EU) 2017/1129)
("PROSPECTUS REGULATION"); (B) PERSONS IN THE UNITED KINGDOM WHO
ARE QUALIFIED INVESTORS WITHIN THE MEANING OF THE UK VERSION OF THE
PROSPECTUS REGULATION WHICH IS PART OF UK LAW BY VIRTUE OF THE
EUROPEAN UNION (WITHDRAWAL) ACT 2018 AS AMED AND SUPPLEMENTED
(INCLUDING BY THE UK PROSPECTUS AMMENT REGULATIONS 2019 AND THE
FINANCIAL SERVICES AND MARKETS ACT 2000 (PROSPECTUS) REGULATIONS
2019) WHO ALSO (I) HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING
TO INVESTMENTS FALLING WITHIN ARTICLE 19(5) OF THE FINANCIAL
SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005
("ORDER") (INVESTMENT PROFESSIONALS) OR (II) FALL WITHIN ARTICLE
49(2)(A) TO (D) OF THE ORDER (HIGH NET WORTH COMPANIES,
UNINCORPORATED ASSOCIATIONS ETC.) AND (C) THOSE PERSONS TO WHOM IT
MAY OTHERWISE BE LAWFULLY COMMUNICATED (EACH SUCH PERSONS REFERRED
TO ABOVE BEING A "RELEVANT PERSON"). THIS ANNOUNCEMENT (INCLUDING
THIS APPIX) AND THE TERMS AND CONDITIONS SET OUT HEREIN MUST NOT BE
ACTED ON OR RELIED ON BY PERSONS WHO ARE NOT RELEVANT PERSONS. ANY
INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT
(INCLUDING THIS APPIX) AND THE TERMS AND CONDITIONS SET OUT HEREIN
RELATES IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED
IN ONLY WITH RELEVANT PERSONS.
THIS APPIX, AND THE ANNOUNCEMENT OF WHICH IT FORMS PART, IS FOR
INFORMATION PURPOSES ONLY IS NOT INTED TO FORM THE BASIS OF ANY
INVESTMENT ACTIVITY OR DECISION, AND SHOULD NOT BE CONSIDERED AS A
RECOMMATION BY THE COMPANY THAT ANY RECIPIENT SHOULD ACQUIRE ANY
INTEREST IN THE SHARE CAPITAL OR ANY OTHER INTEREST IN THE COMPANY.
IT DOES NOT ITSELF CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF
ANY SECURITIES IN THE COMPANY. IF YOU ARE IN ANY DOUBT AS TO
WHETHER YOU ARE A RELEVANT PERSON YOU SHOULD CONSULT A PROFESSIONAL
ADVISER FOR ADVICE.
THIS ANNOUNCEMENT IS NOT AN OFFER FOR SALE OR SUBSCRIPTION IN
ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE
UNLAWFUL UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION. THIS
ANNOUNCEMENT IS NOT AN OFFER OF OR SOLICITATION TO PURCHASE OR
SUBSCRIBE FOR SECURITIES IN THE UNITED STATES. THE SECURITIES
REFERRED TO HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER
THE U.S. SECURITIES ACT OF 1933, AS AMED (THE "SECURITIES ACT"),
AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES EXCEPT PURSUANT
TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT. THE PLACING SHARES ARE BEING OFFERED AND SOLD ONLY
(I) OUTSIDE OF THE UNITED STATES IN "OFFSHORE TRANSACTIONS" AS
DEFINED IN AND IN ACCORDANCE WITH REGULATION S UNDER THE SECURITIES
ACT ("REGULATION S") AND OTHERWISE IN ACCORDANCE WITH APPLICABLE
LAWS AND; (II) IN THE UNITED STATES TO A LIMITED NUMBER OF
"QUALIFIED INSTITUTIONAL BUYERS" ("QIB") AS DEFINED IN RULE 144A
UNDER THE SECURITIES ACT PURSUANT TO AN EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT . THERE WILL BE NO
PUBLIC OFFER OF THE SECURITIES MENTIONED HEREIN IN THE UNITED
STATES.
EACH PLACEE SHOULD CONSULT WITH ITS OWN ADVISERS AS TO LEGAL,
TAX, BUSINESS AND RELATED ASPECTS OF AN INVESTMENT IN PLACING
SHARES. THE PRICE OF THE PLACING SHARES IN THE COMPANY AND THE
INCOME FROM THEM (IF ANY) MAY GO DOWN AS WELL AS UP AND INVESTORS
MAY NOT GET BACK THE FULL AMOUNT INVESTED ON DISPOSAL OF THE
PLACING SHARES.
Placees will be deemed to have read and understood this
announcement and these terms and conditions in their entirety and
to be making such offer on the terms and conditions and to be
providing the representations, warranties, acknowledgements, and
undertakings contained in this Appendix. In particular, each such
Placee represents warrants and acknowledges that:
1. it is a Relevant Person and undertakes that it will acquire,
hold, manage or dispose of any Placing Shares that are allocated to
it for the purposes of its business;
2. in the case of any Placing Shares acquired by it as a
financial intermediary, as that term is used in Article 5(1) of the
Prospectus Regulation, (i) the Placing Shares acquired by it have
not been acquired on behalf of, nor have they been acquired with a
view to their offer or resale to, persons in any Member State of
the EEA or the UK other than Qualified Investors or in
circumstances in which the prior consent of the Joint Bookrunners
has been given to the offer or resale; or (ii) where Placing Shares
have been acquired by it on behalf of persons in any Member State
of the EEA or the UK other than Qualified Investors, the offer of
those Placing Shares to it is not treated under the Prospectus
Regulation as having been made to such persons; and/or
3. except as otherwise permitted by the Company and subject to
any available exemptions from applicable securities laws, it (and
any person on whose account it is acting) is (a) located outside
the United States and is acquiring the Placing Shares in an
"offshore transaction" as defined in, and in accordance with,
Regulation S ; or (b) if within the United States, is a QIB .
The Company and the Joint Bookrunners will rely upon the truth
and accuracy of the foregoing representations, acknowledgements and
agreements. Neither of the Joint Bookrunners makes any
representation to any Placee regarding an investment in the Placing
Shares referred to in this announcement (including this
Appendix).
This announcement (including this Appendix) does not constitute
an offer and may not be used in connection with an offer, to sell
or issue or the solicitation of an offer to buy or subscribe for
Placing Shares in any jurisdiction in which such offer or
solicitation is or may be unlawful. This announcement (including
this Appendix) and the information contained herein is not for
publication or distribution, directly or indirectly, to persons in
the United States, the Excluded Territories or in any jurisdiction
in which such publication or distribution is unlawful. Persons who
come into possession of this announcement are required by the
Company to inform themselves about and to observe any restrictions
of transfer of this announcement. No public offer of securities of
the Company under the Placing is being made in the United Kingdom,
the EEA, the United States, Hong Kong or any Excluded
Territory.
In particular, the Placing Shares referred to in this
announcement have not been and will not be registered under the
Securities Act or under any laws of, or with any securities
regulatory authority of, any state or other jurisdiction of the
United States, and may not be offered, sold, resold, transferred or
delivered, directly or indirectly, in the United States except
pursuant to an exemption from, or in a transaction not subject to,
the registration requirements of the Securities Act and in
compliance with any applicable securities laws of any state or
other jurisdiction in the United States. The Placing Shares are
only being offered and sold only (i) outside the United States in
offshore transactions as defined in and in accordance with
Regulation S; and (ii) in the United States to a limited number of
QIBs pursuant to an exemption from the registration requirements of
the Securities Act.
The relevant clearances have not been, nor will they be,
obtained from the securities commission of any province or
territory of Canada; no prospectus has been lodged with or
registered by the Australian Securities and Investments Commission
or the Japanese Ministry of Finance; and the Placing Shares have
not been, nor will they be, registered under or offered in
compliance with the securities laws of any state, province or
territory of any of the Excluded Territories. Accordingly, the
Placing Shares may not (unless an exemption under the relevant
securities laws is applicable) be offered, sold, resold or
delivered, directly or indirectly, in or into the Excluded
Territories or any other jurisdiction where it would be unlawful to
do so.
Persons (including, without limitation, nominees and trustees)
who have a contractual or other legal obligation to forward a copy
of this Appendix or the announcement of which it forms part should
seek appropriate advice before taking any action.
TIMETABLE FOR THE PLACING
Following the release of this announcement, the Joint
Bookrunners will today commence the Bookbuild to determine demand
for participation in the Placing by Placees. This Appendix gives
details of the terms and conditions of, and the mechanics of
participation in, the Placing. No commissions will be paid to
Placees or by Placees in respect of any Placing Shares.
The Joint Bookrunners and the Company shall be entitled to
effect the Placing by such alternative method to the Bookbuild as
they may, in their sole discretion, determine.
The number of the Placing Shares will be established in the
Bookbuild and announced by the Company through a Regulatory
Information Service following the completion of the Bookbuild and
the entry into the Placing Shares Agreement by the Company and the
Joint Bookrunners.
Various dates referred to in this announcement are stated on the
basis of the expected timetable for the Placing. It is possible
that some of these dates may be changed. The Placing Shares will be
allotted on 8 June 2023, conditional upon Admission becoming
effective on 9 June 2023.
DETAILS OF THE PLACING
The Joint Bookrunners have entered into the Placing Agreement
with the Company under which the Joint Bookrunners have (severally,
and not jointly or jointly and severally), on the terms and subject
to the conditions set out therein, undertaken to use their
respective reasonable endeavours to procure, as agents for the
Company, subscribers for the Placing Shares at the Issue Price.
The Placing Agreement contains customary warranties and
indemnities given by the Company to the Joint Bookrunners as to
matters relating to the Company and its business in respect of
liabilities arising out of, or in connection with, the Placing.
The Bookbuild is expected to close at 11.00 a.m. GMT tomorrow,
19 May 2023 , but may be closed earlier, or later, at the
discretion of the Joint Bookrunners. The Joint Bookrunners may, in
agreement with the Company, accept bids received after the
Bookbuild has closed.
The Joint Bookrunners (after consultation with the Company and
on the basis of allocations agreed between the Company and the
Joint Bookrunners) reserve the right to scale back the number of
Placing Shares to be subscribed by any Placee in the event of
applications in excess of the target amount under the Placing. The
Company and the Joint Bookrunners also reserve the right not to
accept offers to subscribe for Placing Shares or to accept such
offer in part rather than in whole. The Joint Bookrunners shall be
entitled to effect the Placing by such method as they shall in
their sole discretion determine. To the fullest extent permissible
by law, neither of the Joint Bookrunners nor any holding company of
a Joint Bookrunner nor any subsidiary branch or affiliate of a
Joint Bookrunner (each an affiliate) nor any person acting on
behalf of any of the foregoing shall have any liability to the
Placees (or to any other person whether acting on behalf of a
Placee or otherwise). In particular, neither of the Joint
Bookrunners, nor any affiliate thereof nor any person acting on
their respective behalves shall have any liability to Placees in
respect of their conduct of the Bookbuild or the Placing.
Each Placee's obligations will be owed to the Company and to the
Joint Bookrunners. Following the confirmation referred to below in
the paragraph entitled "Participation in, and principal terms of,
the Placing", each Placee will also have an immediate, separate,
irrevocable and binding obligation, owed to the Joint Bookrunners,
to pay to Panmure Gordon or Shore Capital (as the case maybe) (or
as they shall each respectively direct) in cleared funds an amount
equal to the product of the Issue Price and the number of Placing
Shares which such Placees has agreed to acquire.
Each Placee and any person acting on behalf of such Placee
agrees to indemnify on demand and hold each of the Joint
Bookrunners and the Company, and their respective affiliates
harmless from any costs, claims, liabilities and expenses
(including legal fees and expenses) arising out of or in connection
with any breach of the acknowledgments, undertakings,
representations, warranties and agreements set forth in these terms
and conditions and any contract note.
The Placing is also conditional upon the Placing Agreement
becoming unconditional and the Placing Agreement not being
terminated in accordance with its terms. Further details of
conditions in relation to the Placing are set out below in the
paragraph entitled "Conditions of the Placing". All obligations
under the Placing will be subject to the fulfilment of the
conditions referred to below in the paragraph entitled "Conditions
of the Placing".
To the fullest extent permitted by law, each Placee acknowledges
and agrees that it will not be entitled to exercise any remedy of
rescission at any time. This does not affect any other rights the
Placee may have.
APPLICATION FOR ADMISSION TO TRADING
Application will be made to the London Stock Exchange for the
Admission of the Placing Shares and Admission is expected to become
effective at 8.00 a.m. on or around 9 June 2023 and dealings in the
Placing Shares will commence at that time.
Settlement of transactions in the Placing Shares following
Admission will take place within the system administered by CREST,
subject to certain exceptions. The Company reserves the right to
require settlement for and delivery of the Placing Shares to
Placees in certificated form if either of the Joint Bookrunners or
the Company in its absolute discretion considers this to be
necessary or desirable.
PAYMENT FOR SHARES
Each Placee has a separate, irrevocable and binding obligation
to pay the Issue Price in cleared funds for the number of Placing
Shares duly allocated to the Placee under the Placing in the manner
and by the time directed by the Joint Bookrunners. If any Placee
fails to pay as so directed and/or by the time directed, the
relevant Placee's application for Placing Shares shall at the Joint
Bookrunners' discretion either be rejected or accepted in which
case the paragraph below entitled "Registration and Settlement"
shall apply to such application.
PARTICIPATION IN, AND PRINCIPAL TERMS OF, THE PLACING
Each Joint Bookrunner (whether through itself or any of its
affiliates) is arranging the Placing as placing agent of the
Company and using its reasonable endeavours to procure Placees at
the Issue Price for the Placing Shares.
Participation in the Placing will only be available to persons
who may lawfully be, and are, invited to participate by the Joint
Bookrunners. The Joint Bookrunners and its affiliates may
participate in the Placing as principal.
By participating in the Placing, Placees will be deemed to have
read and understood this announcement, including this Appendix, in
its entirety and to be participating and making an offer for
Placing Shares on the terms and conditions, and to be providing the
representations, warranties, acknowledgements, agreements and
undertakings contained in this Appendix.
This Appendix gives details of the terms and conditions of, and
the mechanics of participation in, the Placing. No commissions will
be paid to Placees or by Placees in respect of any Placing
Shares.
The number of Placing Shares to be issued, and the extent of
each Placee's participation in the Placing (which will not
necessarily be the same for each Placee), will be agreed between
the Joint Bookrunners and the Company following completion of the
bookbuilding process in respect of the Placing (the "Bookbuild").
No element of the Placing will be underwritten. The aggregate
number of Placing Shares will be announced on a Regulatory
Information Service following completion of the Bookbuild.
A Placee's commitment to acquire a fixed number of Placing
Shares under the Placing will be agreed orally or by email with a
Joint Bookrunner as agent of the Company. Each Placee's allocation
will be confirmed to Placees orally or by email by the relevant
Joint Bookrunner, and a form of confirmation will be dispatched as
soon as possible thereafter. The oral or email confirmation to such
Placee will constitute an irrevocable legally binding commitment
upon such person (who will at that point become a Placee) in favour
of the Joint Bookrunners and the Company, under which it agrees to
acquire the number of Placing Shares allocated to it at the Issue
Price on the terms and conditions set out in this Appendix and in
accordance with the articles of incorporation of the Company.
Except as required by law or regulation, no press release or
other announcement will be made by the Joint Bookrunners or the
Company using the name of any Placee (or its agent), in its
capacity as Placee (or agent), other than with such Placee's prior
written consent.
Irrespective of the time at which a Placee's allocation pursuant
to the Placing is confirmed, settlement for all Placing Shares to
be acquired pursuant to the Placing will be required to be made on
the basis explained below under the paragraph entitled
"Registration and Settlement".
All obligations under the Placing will be subject to fulfilment
or (where applicable) waiver of, amongst other things, the
conditions referred to below and to the Placing not being
terminated on the basis referred to below.
By participating in the Placing, each Placee will agree that its
rights and obligations in respect of the Placing will terminate
only in the circumstances described below and will not be capable
of rescission or termination by the Placee.
To the fullest extent permissible by law, none of the Company,
the Joint Bookrunners or any of their respective affiliates shall
have any liability to Placees (or to any other person whether
acting on behalf of a Placee or otherwise under these terms and
conditions). In particular, none of the Company, the Joint
Bookrunners or any of its respective affiliates shall have any
liability (including to the fullest extent permissible by law, any
fiduciary duties) in respect of the Joint Bookrunners' conduct of
the Placing. Each Placee acknowledges and agrees that the Company
is responsible for the issue of the Placing Shares to the Placees
and the Joint Bookrunners shall have no liability to the Placees
for the failure of the Company to fulfil those obligations.
CONDITIONS OF THE PLACING
The Placing is conditional upon the Placing Agreement becoming
unconditional and not having been terminated in accordance with its
terms.
The Joint Bookrunners' obligations under the Placing Agreement
(which are several and not joint, or joint and several) in respect
of the Placing Shares are conditional on, inter alia:
1. the passing of the Resolutions relating to the Placing, the
Retail Offer and the Open Offer at the General Meeting;
2. the Company allotting, subject only to Admission, the Placing
Shares in accordance with the Placing Agreement;
3. none of the warranties given by the Company in the Placing
Agreement being untrue, inaccurate or misleading to an extent which
would be material as at the date of the Placing Agreement or at any
time between the date of the Placing Agreement and Admission;
4. Admission having occurred by no later than 8.00 a.m. on or
around 9 June 2023 or such later date as the Company and the Joint
Bookrunners may agree, but in any event not later than the Placing
Long Stop Date; and
5. the Company having complied with its obligations under the Placing Agreement.
For the avoidance of doubt the Placing is not conditional on any
of the Retail Offer, the Open Offer, the issuance of the
Convertible Loan Notes or the Minimum Amount being raised by the
Fundraise.
If (a) any of the conditions contained in the Placing Agreement
in relation to the Placing Shares are not fulfilled or waived by
the Joint Bookrunners by the respective time or date where
specified (or such later time or date as the Company and the Joint
Bookrunners may agree not being later than 8.00 a.m. on 23 June
2023 (the "Placing Long Stop Date"); or (b) the Placing Agreement
is terminated as described below, the Placing in relation to the
Placing Shares will lapse and the Placee's rights and obligations
hereunder in relation to the Placing Shares shall cease and
terminate at such time and each Placee agrees that no claim can be
made by the Placee in respect thereof.
Subject to certain exceptions, the Joint Bookrunners may, at
their absolute discretion and upon such terms as they think fit,
waive, or extend the period (up to the Placing Long Stop Date) for,
compliance by the Company with the whole or any part of any of the
Company's obligations in relation to the conditions in the Placing
Agreement. Any such extension or waiver will not affect Placees'
commitments as set out in this announcement.
Neither of the Joint Bookrunners nor the Company shall have any
liability to any Placee (or to any other person whether acting on
behalf of a Placee or otherwise) in respect of any decision they
may make as to whether or not to waive or to extend the time and/or
date for the satisfaction of any condition to the Placing nor for
any decision they may make as to the satisfaction of any condition
or in respect of the Placing generally and by participating in the
Placing each Placee agrees that any such decision is within the
absolute discretion of the Joint Bookrunners.
RIGHT TO TERMINATE UNDER THE PLACING AGREEMENT
Either Joint Bookrunners is entitled, at any time before
Admission, to terminate the Placing Agreement by giving notice to
the Company in certain circumstances, including, inter alia:
1. the Company is in breach of any of its material obligations
under the Placing Agreement or cannot comply with such material
obligation; or
2. any of the warranties given by the Company to the Joint
Bookrunners under the Placing Agreement is, or if repeated at any
time up to Admission would cause it to be, untrue, inaccurate or
misleading in any material respect; or
3. a matter having arisen prior to Admission in respect of which
a claim for indemnification under the Placing Agreement may be
sought;
4. if, amongst other things, there is a substantial change in
any national or international political, military, diplomatic,
economic, financial or market conditions which in the Joint
Bookrunner's opinion (acting in good faith and after such
consultation with the Company or the other Joint Bookrunner as
shall be practicable in the circumstances) would have or be likely
to have a material and adverse effect on the Placing, the Retail
Offer or Open Offer, or dealings in New Ordinary Shares in the
secondary market or is of such magnitude to render the Fundraise,
or the creation of a market in the New Ordinary Shares temporarily
or permanently impracticable or inadvisable; or
5. if it comes to the notice of the Joint Bookrunner that any
statement contained in any Placing Document become untrue,
inaccurate or misleading in any material respect or matters have
arisen which would, if the Circular was issued at that time,
constitute a material omission therefrom.
Following Admission, the Placing Agreement is not capable of
termination to the extent it relates to the Placing of any of the
Placing Shares.
The rights and obligations of the Placees shall terminate only
in the circumstances described in these terms and conditions and in
the Placing Agreement and will not be subject to termination by the
Placee or any prospective Placee at any time or in any
circumstances. By participating in the Placing, Placees agree that
the exercise by a Joint Bookrunner of any right of termination or
other discretion under the Placing Agreement shall be within the
absolute discretion of such Joint Bookrunner and that it need not
make any reference to Placees and that it shall have no liability
to Placees whatsoever in connection with any such exercise or
decision not to exercise. Placees will have no rights against the
Joint Bookrunners, the Company or any of their respective directors
or employees under the Placing Agreement pursuant to the Contracts
(Rights of Third Parties) Act 1999 (as amended).
NO PROSPECTUS
The Placing Shares are being offered to Relevant Persons only
and will not be offered in such a way as to require a prospectus in
the United Kingdom or elsewhere under the Prospectus Regulation
Rules Sourcebook published by the FCA. No offering document or
prospectus has been or will be submitted to be approved by the FCA
or any other party in relation to the Placing and Placees'
commitments will be made solely on the basis of the information
contained in this announcement (including this Appendix) and
certain business and financial information the Company is required
to publish in accordance with the Companies Act 2006, the AIM Rules
and the rules and practices of the FCA (collectively "Exchange
Information"), save that in the case of Exchange Information a
Placee's right to rely on that information is limited to the right
that such Placee would have as a matter of law in the absence of
this paragraph .
Each Placee, by accepting a participation in the Placing, agrees
that the content of this announcement, including this Appendix, is
exclusively the responsibility of the Company and confirms that it
has not relied on any other information (other than the Exchange
Information), representation, warranty, or statement made by or on
behalf of the Company or the Joint Bookrunners or any other person
and neither of the Joint Bookrunners nor the Company nor any other
person will be liable for any Placee's decision to participate in
the Placing based on any other information, representation,
warranty or statement which the Placees may have obtained or
received. Each Placee acknowledges and agrees that it has relied on
its own investigation of the business, financial or other position
of the Company in accepting a participation in the Placing. Nothing
in this paragraph shall exclude the liability of any person for
fraudulent misrepresentation.
REGISTRATION AND SETTLEMENT
Settlement of transactions in the Placing Shares (ISIN:
GB00B11SZ269) following Admission will take place within the
relevant system administered by Euroclear, being CREST provided
that, subject to certain exceptions, the Joint Bookrunners reserve
the right to require settlement for, and delivery of, the Placing
Shares (or a portion thereof) to Placees by such other means that
they deem necessary if delivery or settlement is not possible or
practicable within CREST within the timetable set out in this
announcement or would not be consistent with the regulatory
requirements in any Placee's jurisdiction. The Company reserves the
right to require settlement for and delivery of the Placing Shares
to Placees in certificated form if any of the Joint Bookrunners or
the Company in its absolute discretion considers this to be
necessary or desirable.
Following the close of the Bookbuild, each Placee allocated
Placing Shares in the Placing will be sent a form of confirmation
stating the number of Placing Shares allocated to it at the Issue
Price, the aggregate amount owed by such Placee to the relevant
Joint Bookrunner (as agent for the Company) and settlement
instructions (including the trade date which will be 19 May 2023).
Each Placee agrees that it will do all things necessary to ensure
that delivery and payment is completed in accordance with either
the CREST or certificated settlement instructions that it has in
place with the relevant Joint Bookrunner. Each Placee will also be
sent a trade confirmation on the trade date (referred to above)
confirming the details of the trade (being the acquisition of the
relevant number of Placing Shares).
Admission and settlement may occur at an earlier date.
Settlement will be on a delivery versus payment basis. However, in
the event of any difficulties or delays in the admission of the
Placing Shares to CREST or the use of CREST in relation to the
Placing, the Company and the Joint Bookrunners may agree that the
Placing Shares should be issued in certificated form. The Joint
Bookrunners and the Company reserves the right to require
settlement for the Placing Shares, and to deliver the Placing
Shares to Placees, by such other means as they deem necessary if
delivery or settlement to Placees is not practicable within the
CREST system or would not be consistent with regulatory
requirements in a Placee's jurisdiction.
Interest is chargeable daily on payments not received from
Placees on the due date in accordance with the arrangements set out
above at the rate of two percentage points above LIBOR as
determined by the relevant the Joint Bookrunner.
Each Placee is deemed to agree that, if it does not comply with
these obligations, the Joint Bookrunners (or either of them) may
sell any or all of the Placing Shares allocated to that Placee on
such Placee's behalf and retain from the proceeds, for the relevant
the Joint Bookrunners' account and benefit (as agent for the
Company), an amount equal to the aggregate amount owed by the
Placee plus any interest due. Any excess proceeds will pass to the
relevant Placee at its risk. The relevant Placee will, however,
remain liable and shall indemnify the Joint Bookrunners on demand
for any shortfall below the aggregate amount owed by it and may be
required to bear any stamp duty or stamp duty reserve tax or
securities transfer tax (together with any interest or penalties)
which may arise upon the sale of such Placing Shares on such
Placee's behalf. By communicating a bid for Placing Shares, each
Placee confers on the Joint Bookrunners all such authorities and
powers necessary to carry out any such sale and agrees to ratify
and confirm all actions which the Joint Bookrunners lawfully takes
in pursuance of such sale.
If Placing Shares are to be delivered to a custodian or
settlement agent, Placees should ensure that the form of
confirmation is copied and delivered immediately to the relevant
person within that organisation.
Insofar as Placing Shares are registered in a Placee's name or
that of its nominee or in the name of any person for whom a Placee
is contracting as agent or that of a nominee for such person, such
Placing Shares should, subject as provided below, be so registered
free from any liability to UK stamp duty or stamp duty reserve tax
or securities transfer tax. Placees will not be entitled to receive
any fee or commission in connection with the Placing.
REPRESENTATIONS, WARRANTIES AND FURTHER TERMS
By submitting a bid and/or participating in the Placing, each
Placee (and any person acting on such Placee's behalf) makes the
following representations, warranties, acknowledgements, agreements
and undertakings (as the case may be) to the Company and the Joint
Bookrunners, namely that, each Placee (and any person acting on
such Placee's behalf):
1. represents and warrants that it has read and understood this
announcement, including this Appendix, in its entirety and that its
subscription for and purchase of the Placing Shares is subject to,
and based upon, all the terms, conditions, representations,
warranties, acknowledgements, agreements and undertakings and other
information contained herein and undertakes not to redistribute or
duplicate this announcement (including this Appendix);
2. acknowledges that no offering document or prospectus has been
prepared in connection with the placing of the Placing Shares and
represents and warrants that it has not received and will not
receive a prospectus, admission document or other offering document
in connection therewit h;
3. acknowledges that the Ordinary Shares are admitted to trading
on AIM, and the Company is therefore required to publish Exchange
Information, which includes a description of the nature of the
Company's business and the Company's most recent balance sheet and
profit and loss account and that the Placee is able to obtain or
access such information without undue difficulty, and is able to
obtain access to such information or comparable information
concerning any other publicly traded company, without undue
difficult y;
4. acknowledges that the content of this announcement (including
this Appendix) is exclusively the responsibility of the Company,
and that neither Joint Bookrunner, their respective affiliates or
any person acting on their behalf has or shall have any liability
for any information, representation or statement contained in this
announcement (including this Appendix) or any information
previously or concurrently published by or on behalf of the Company
(including any Exchange Information), and will not be liable for
any Placee's decision to participate in the Placing based on any
information, representation or statement contained in this
announcement (including this Appendix) or otherwise. Each Placee
further represents, warrants and agrees that the only information
on which it is entitled to rely and on which such Placee has relied
in committing itself to acquire the Placing Shares is contained in
this announcement (including this Appendix) and any Exchange
Information (save that in the case of Exchange Information, a
Placee's right to rely on that information is limited to the right
that such Placee would have as a matter of law in the absence of
this paragraph) , such information being all that it deems
necessary to make an investment decision in respect of the Placing
Shares and that it has neither received nor relied on any other
information given or representations, warranties or statements made
by the Joint Bookrunners or the Company or any of their respective
directors, officers or employees or any person acting on behalf of
any of them (including with respect to the Company, the Placing,
the Placing Shares or the accuracy, completeness or adequacy of any
publicly available information), or, if received, it has not relied
upon any such information, representations, warranties or
statements, and neither of the Joint Bookrunners nor the Company
will be liable for any Placee's decision to accept an invitation to
participate in the Placing based on any other information,
representation, warranty or statement. Each Placee further
acknowledges and agrees that it may not place the same degree of
reliance on this announcement as it may otherwise place on a
prospectus or admission document. Each Placee further acknowledges
and agrees that it has relied solely on its own investigation of
the business, financial or other position of the Company and the
terms of the Placing in deciding to participate in the Placing and
it will not rely on any investigation that the Joint Bookrunners,
their affiliates or any other person acting on their behalf has or
may have conducte d;
5. represents and warrants that it has neither received nor
relied on any confidential price sensitive information concerning
the Company in accepting this invitation to participate in the
Placin g;
6. time is of the essence as regards its obligations under this announcemen t;
7. acknowledges that the Joint Bookrunners do not have any
duties or responsibilities to it, or its clients, similar or
comparable to the duties of "best execution" and "suitability"
imposed by the Conduct of Business Sourcebook in the FCA's Handbook
of Rules and Guidance and that neither Panmure Gordon nor Shore
Capital is acting for it or its clients and that the Joint
Bookrunners will not be responsible for providing protections to
their respective client s;
8. acknowledges that neither of the Joint Bookrunners, any of
their affiliates or any persons acting on behalf of them has or
shall have any liability for any publicly available or filed
information (including any Exchange Information) or any
representation relating to the Company, provided that nothing in
this paragraph excludes the liability of any person for fraudulent
misrepresentation made by that perso n;
9. that, save in the event of fraud on the part of the relevant
Joint Bookrunners (and to the extent permitted by the FCA), neither
of the Joint Bookrunners, their respective ultimate holding
companies nor any direct or indirect subsidiary undertakings of
such holding companies, nor any of their respective directors and
employees shall be liable to Placees for any matter arising out of
either Joint Bookrunners' role as placing agent or otherwise in
connection with the Placing and that where any such liability
nevertheless arises as a matter of law, Placees will immediately
waive any claim against any of such persons which it may have in
respect thereo f;
10. represents and warrants that it is not a person located in
the United States and is eligible to participate in an "offshore
transaction" as defined in and in accordance with Regulation S and
the Placing Shares were not offered to it by means of "directed
selling efforts" as defined in Regulation S;
11. unless otherwise specifically agreed in writing with the
Joint Bookrunners, represents and warrants that neither it nor the
beneficial owner of such Placing Shares will be a resident of an
Excluded Territor y;
12. acknowledges that the Placing Shares have not been and will
not be registered under the securities legislation of Excluded
Territories and, subject to certain exceptions, may not be offered,
sold, taken up, renounced or delivered or transferred, directly or
indirectly, within those jurisdiction s;
13. that, in relation to any Placee located in Hong Kong, it is
a professional investor as defined under the Securities and Futures
Ordinance (Cap. 571 );
14. represents and warrants that the issue to it, or the person
specified by it for registration as holder, of Placing Shares will
not give rise to a liability under any of sections 67, 70, 93 or 96
of the Finance Act 1986 (depositary receipts and clearance
services) and that the Placing Shares are not being acquired in
connection with arrangements to issue depositary receipts or to
transfer Placing Shares into a clearance syste m;
15. represents and warrants that: (i) it has complied with and
will continue to comply with its obligations under the Market Abuse
Regulation (EU) No. 596/2014 (or the Market Abuse Regulation (EU)
No. 596/2014 as retained in UK law), Criminal Justice Act 1993 and
Part VIII of the Financial Services and Markets Act 2000, as
amended ("FSMA") and other applicable law; (ii) in connection with
money laundering and terrorist financing, it has complied with its
obligations under the Proceeds of Crime Act 2002 (as amended), the
Terrorism Act 2000 (as amended), the Terrorism Act 2006, the Money
Laundering, Terrorist Financing and Transfer of Funds (Information
on the Payer) 2017 Regulations, and any other applicable law (where
all such legislation listed under this (ii) shall together be
referred to as the "AML Legislation"); and (iii) it is not a
person: (1) with whom transactions are prohibited under the Foreign
Corrupt Practices Act of 1977 or any economic sanction programmes
administered by, or regulations promulgated by, the Office of
Foreign Assets Control of the U.S. Department of the Treasury; (2)
named on the Consolidated List of Financial Sanctions Targets
maintained by HM Treasury of the United Kingdom; or (3) subject to
financial sanctions imposed pursuant to a regulation of the EU or a
regulation adopted by the United Nations (together, the
"Regulations"); and, if making payment on behalf of a third party,
that satisfactory evidence has been obtained and recorded by it to
verify the identity of the third party as required by the
Regulations and pursuant to AML Legislation and has obtained all
governmental and other consents (if any) which may be required for
the purpose of, or as a consequence of, such purchase, and it will
provide promptly to the Joint Bookrunners or the Company such
evidence, if any, as to the identity or location or legal status of
any person (including in relation to the beneficial ownership of
any underlying investor) which the Joint Bookrunners or the Company
may request from it in connection with the Placing (for the purpose
of complying with such Regulations or ascertaining the nationality
of any person or the jurisdiction(s) to which any person is subject
or otherwise or any other information as may be required to comply
with legal or regulatory requirements (including in particular
under the AML Legislation)) in the form and manner requested by the
Joint Bookrunners or the Company on the basis that any failure by
it to do so may result in the number of Placing Shares that are to
be purchased by it or at its direction pursuant to the Placing
being reduced to such number, or to nil, as the Joint Bookrunners
and the Company may decide at their sole discretio n;
16. if a financial intermediary, as that term is used in Article
5(1) of the UK Prospectus Regulation, represents and warrants that
the Placing Shares purchased by it in the Placing will not be
acquired on a non-discretionary basis on behalf of, nor will they
be acquired with a view to their offer or resale to, persons in a
Member State of the EEA or the UK other than EU Qualified Investors
or UK Qualified Investors respectively, or in circumstances in
which the prior consent of the Joint Bookrunners has been given to
the offer or resal e;
17. represents and warrants that it has not offered or sold and
will not offer or sell any Placing Shares to persons in the EEA or
the UK prior to Admission except to persons whose ordinary
activities involve them in acquiring, holding, managing or
disposing of investments (as principal or agent) for the purposes
of their business or otherwise in circumstances which have not
resulted in and which will not result in an offer to the public in
any Member State of the EEA or the UK within the meaning of the EU
Prospectus Regulation or UK Prospectus Regulation respectivel
y;
18. represents and warrants that it has only communicated or
caused to be communicated and will only communicate or cause to be
communicated any invitation or inducement to engage in investment
activity (within the meaning of section 21 of the FSMA) relating to
the Placing Shares in circumstances in which section 21(1) of the
FSMA does not require approval of the communication by an
authorised perso n;
19. represents and warrants that it has complied and will comply
with all applicable provisions of the FSMA and the Financial
Services Act 2012 with respect to anything done by it in relation
to the Placing Shares in, from or otherwise involving, the United
Kingdo m;
20. if in the United Kingdom, represents and warrants that it is
a UK Qualified Investor who: (i) falls with Articles 49(2)(A) to
(D) or 19(5) of the Financial Promotion Order or (ii) it is a
person to whom the Placing Shares may otherwise be lawfully offered
under the Financial Promotion Order or, if it is receiving the
offer in circumstances under which the laws or regulations of a
jurisdiction other than the United Kingdom would apply, it is a
person to whom the Placing Shares may be lawfully offered under
that other jurisdiction's laws and regulations; and (iii) is a
"professional client" or an "eligible counterparty" within the
meaning of Chapter 3 of the FCA's Conduct of Business Sourceboo
k;
21. represents and warrants that it and any person acting on its
behalf is entitled to acquire the Placing Shares under the laws of
all relevant jurisdictions and that it has all necessary capacity
and has obtained all necessary consents and authorities and taken
any other necessary actions to enable it to commit to this
participation in the Placing and to perform its obligations in
relation thereto (including, without limitation, in the case of any
person on whose behalf it is acting, all necessary consents and
authorities to agree to the terms set out or referred to in this
announcement (including this Appendix)) and will honour such
obligation s;
22. represents and warrants that it is not, and it is not acting
on behalf of, a Sanctioned Shareholde r;
23. where it is acquiring Placing Shares for one or more managed
accounts, represents and warrants that it is authorised in writing
by each managed account: (i) to acquire the Placing Shares for each
managed account; (ii) to make on its behalf the representations,
warranties, acknowledgements, undertakings and agreements in this
Appendix and the announcement of which it forms part; and (iii) to
receive on its behalf any investment letter relating to the Placing
in the form provided to it by a Joint Bookrunne r;
24. undertakes that it (and any person acting on its behalf)
will make payment for the Placing Shares allocated to it in
accordance with this announcement (including this Appendix) on the
due time and date set out herein, failing which the relevant
Placing Shares may be placed with other subscribers or sold as the
Joint Bookrunners may in their sole discretion determine and
without liability to such Placee and it will remain liable and will
indemnify the Joint Bookrunners on demand for any shortfall below
the net proceeds of such sale and the placing proceeds of such
Placing Shares and may be required to bear the liability for any
stamp duty or stamp duty reserve tax or security transfer tax
(together with any interest or penalties due pursuant to or
referred to in these terms and conditions) which may arise upon the
placing or sale of such Placee's Placing Shares on its behal f;
25. acknowledges that neither of the Joint Bookrunners, nor any
of their respective affiliates, or any person acting on behalf of
any of them, is making any recommendations to it, advising it
regarding the suitability of any transactions it may enter into in
connection with the Placing and that participation in the Placing
is on the basis that it is not and will not be treated for these
purposes as a client of either Joint Bookrunner and that either of
the Joint Bookrunners does not have any duties or responsibilities
to it for providing the protections afforded to their respective
clients or customers or for providing advice in relation to the
Placing nor in respect of any representations, warranties,
undertakings or indemnities contained in the Placing Agreement nor
for the exercise or performance of any of their rights and
obligations thereunder, including any rights to waive or vary any
conditions or exercise any termination righ t;
26. undertakes that the person whom it specifies for
registration as holder of the Placing Shares will be (i) itself; or
(ii) its nominee, as the case may be. Neither of the Joint
Bookrunners nor the Company will be responsible for any liability
to stamp duty or stamp duty reserve tax resulting from a failure to
observe this requirement. Each Placee and any person acting on
behalf of such Placee agrees to participate in the Placing and it
agrees to indemnify the Company and the Joint Bookrunners in
respect of the same on the basis that the Placing Shares will be
issued to the CREST stock account of a Joint Bookrunner who will
hold them as nominee on behalf of such Placee until settlement in
accordance with its standing settlement instruction s;
27. acknowledges that these terms and conditions and any
agreements entered into by it pursuant to these terms and
conditions and any non-contractual obligations arising out of or in
connection with such agreement shall be governed by and construed
in accordance with the laws of England and it submits (on behalf of
itself and on behalf of any person on whose behalf it is acting) to
the exclusive jurisdiction of the English courts as regards any
claim, dispute or matter (including non-contractual matters)
arising out of any such contract, except that enforcement
proceedings in respect of the obligation to make payment for the
Placing Shares (together with any interest chargeable thereon) may
be taken by the Company or a Joint Bookrunner in any jurisdiction
in which the relevant Placee is incorporated or in which any of its
securities have a quotation on a recognised stock exchang e;
28. agrees that the Company, the Joint Bookrunners and their
respective affiliates and others will rely upon the truth and
accuracy of the foregoing representations, warranties,
acknowledgements and undertakings which are given to each of the
Joint Bookrunners on its own behalf and on behalf of the Company
and are irrevocable and are irrevocably authorised to produce this
announcement or a copy thereof to any interested party in any
administrative or legal proceeding or official inquiry with respect
to the matters covered hereb y;
29. agrees to indemnify on an after-tax basis and hold the
Company, the Joint Bookrunners and their respective affiliates
harmless from any and all costs, claims, liabilities and expenses
(including legal fees and expenses) arising out of or in connection
with any breach of the representations, warranties,
acknowledgements, agreements and undertakings in this Appendix and
that the provisions of this Appendix shall survive after completion
of the Placing and, further agrees if any of the foregoing is or
becomes no longer true or accurate, the Placee shall promptly
notify the Company and the Joint Bookrunner s;
30. acknowledges that no action has been or will be taken by any
of the Company, the Joint Bookrunners or any person acting on
behalf of the Company or the Joint Bookrunners that would, or is
intended to, permit a public offer of the Placing Shares in any
country or jurisdiction where any such action for that purpose is
require d;
31. acknowledges that it is an institution that has knowledge
and experience in financial, business and international investment
matters as is required to evaluate the merits and risks of
subscribing for the Placing Shares. It further acknowledges that it
is experienced in investing in securities of this nature and in
this sector and is aware that it may be required to bear, and it,
and any accounts for which it may be acting, are able to bear, the
economic risk of, and is able to sustain, a complete loss in
connection with the Placing. It has relied upon its own examination
and due diligence of the Company and its associates taken as a
whole, and the terms of the Placing, including the merits and risks
involve d;
32. acknowledges that its commitment to subscribe for Placing
Shares on the terms set out herein will continue, notwithstanding
any amendment that may in the future be made to the terms of the
Placing and that Placees will have no right to be consulted or
require that their consent be obtained with respect to the
Company's conduct of the Placin g;
33. acknowledges that a Joint Bookrunner or any of its
affiliates acting as an investor for its own account may take up
shares in the Company and in that capacity may retain, purchase or
sell for its own account such shares and may offer or sell such
shares other than in connection with the Placin g;
34. represents and warrants that, if it is a pension fund or
investment company, its purchase of Placing Shares is in full
compliance with all applicable laws and regulation; a nd
35. to the fullest extent permitted by law, it acknowledges and
agrees to the disclaimers contained in the announcement, including
this Appendi x.
The representations, warranties, acknowledgments and
undertakings contained in this Appendix are given to the Joint
Bookrunners and the Company and are irrevocable and shall not be
capable of termination in any circumstances.
The agreement to settle a Placee's subscription (and/or the
subscription of a person for whom such Placee is contracting as
agent) free of stamp duty and stamp duty reserve tax depends on the
settlement relating only to a subscription by it and/or such person
direct from the Company for the Placing Shares in question. Such
agreement assumes that the Placing Shares are not being subscribed
for in connection with arrangements to issue depositary receipts or
to transfer the Placing Shares into a clearance service. If there
are any such arrangements, or the settlement relates to any other
subsequent dealing in the Placing Shares, stamp duty or stamp duty
reserve tax may be payable, for which neither the Company nor the
Joint Bookrunners will be responsible, and the Placee to whom (or
on behalf of whom, or in respect of the person for whom it is
participating in the Placing as an agent or nominee) the
allocation, issue or delivery of Placing Shares has given rise to
such UK stamp duty or stamp duty reserve tax undertakes to pay such
UK stamp duty or stamp duty reserve tax forthwith and to indemnify
on an after-tax basis and to hold harmless the Company and the
Joint Bookrunners in the event that any of the Company and/or the
Joint Bookrunners has incurred any such liability to UK stamp duty
or stamp duty reserve tax. If this is the case, each Placee should
seek its own advice and notify the Joint Bookrunners
accordingly.
In addition, Placees should note that they will be liable for
any stamp duty and all other stamp, issue, securities, transfer,
registration, documentary or other duties or taxes (including any
interest, fines or penalties relating thereto) payable outside the
UK by them or any other person on the subscription by them of any
Placing Shares or the agreement by them to subscribe for any
Placing Shares.
Each Placee, and any person acting on behalf of the Placee,
acknowledges that the Joint Bookrunners does not owe any fiduciary
or other duties to any Placee in respect of any representations,
warranties, undertakings or indemnities in the Placing
Agreement.
Each Placee and any person acting on behalf of the Placee
acknowledges and agrees that the Joint Bookrunners or any of their
affiliates may, at their absolute discretion, agree to become a
Placee in respect of some or all of the Placing Shares.
When a Placee or person acting on behalf of the Placee is
dealing with a Joint Bookrunner any money held in an account with
such Joint Bookrunner on behalf of the Placee and/or any person
acting on behalf of the Placee will not be treated as client money
within the meaning of the rules and regulations of the FCA made
under the FSMA. The Placee acknowledges that the money will not be
subject to the protections conferred by the client money rules; as
a consequence, this money will not be segregated from the relevant
Joint Bookrunners' money in accordance with the client money rules
and will be used by that Joint Bookrunner in the course of its own
business and the Placee will rank only as a general creditor of
that Joint Bookrunner.
All times and dates in this announcement (including this
Appendix) may be subject to amendment, and Placees' commitments,
representations and warranties are not conditional on any of the
expected times and dates in this announcement (including this
Appendix) being achieved. The Joint Bookrunners shall notify the
Placees and any person acting on behalf of the Placees of any
changes.
Past performance is no guide to future performance and persons
needing advice should consult an appropriately qualified
independent financial adviser.
A Joint Bookrunner is entitled, at its discretion and out of its
own resources, at any time to rebate to some or all of its
investors, or to other parties, part or all of its fees relating to
the Placing.
MISCELLANEOUS
Solely for the purposes of the product governance requirements
contained within: (a) EU Directive 2014/65/EU on markets in
financial instruments, as amended ("MiFID II"); (b) Articles 9 and
10 of Commission Delegated Directive (EU) 2017/593 supplementing
MiFID II; and (c) local implementing measures, each as they form
part of the law of England and Wales by virtue of EUWA (together,
the "Product Governance Requirements"), and disclaiming all and any
liability, whether arising in tort, contract or otherwise, which
any "manufacturer" (for the purposes of the Product Governance
Requirements) may otherwise have with respect thereto, the Placing
Shares have been subject to a product approval process, which has
determined that the Placing Shares are: (i) compatible with an end
target market of retail investors and investors who meet the
criteria of professional clients and eligible counterparties, each
as defined in MiFID II; and (ii) eligible for distribution through
all distribution channels as are permitted by MiFID II (the "Target
Market Assessment"). Notwithstanding the Target Market Assessment,
Placees should note that: the price of the Placing Shares may
decline and investors could lose all or part of their investment;
the Placing Shares offer no guaranteed income and no capital
protection; and an investment in the Placing Shares is compatible
only with investors who do not need a guaranteed income or capital
protection, who (either alone or in conjunction with an appropriate
financial or other adviser) are capable of evaluating the merits
and risks of such an investment and who have sufficient resources
to be able to bear any losses that may result therefrom. The Target
Market Assessment is without prejudice to the requirements of any
contractual, legal or regulatory selling restrictions in relation
to the Placing. Furthermore, it is noted that, notwithstanding the
Target Market Assessment, the Joint Bookrunners will only procure
investors who meet the criteria of professional clients and
eligible counterparties. For the avoidance of doubt, the Target
Market Assessment does not constitute: (a) an assessment of
suitability or appropriateness for the purposes of MiFID II; or (b)
a recommendation to any investor or Company of investors to invest
in, or purchase, or take any other action whatsoever with respect
to the Placing Shares.
Each distributor is responsible for undertaking its own target
market assessment in respect of the Placing Shares and determining
appropriate distribution channels.
The content of this announcement has been issued by, and is the
sole responsibility of, Velocys plc.
The information contained in this announcement is given at the
date of its publication (unless otherwise marked) and is subject to
updating, revision and amendment from time to time. Neither the
content of the Company's website nor any website accessible by
hyperlinks to the Company's website is incorporated in, or forms
part of, this announcement.
Panmure Gordon (UK) Limited, which is authorised and regulated
in the United Kingdom by the FCA, is acting as nominated adviser,
joint bookrunner and joint broker to the Company in connection with
the Placing and Admission and to no-one else and will not be
responsible to anyone other than the Company for providing the
protections afforded to its clients, nor for providing advice in
relation to the Placing or Admission or any other matter referred
to in this announcement. Panmure Gordon's responsibilities as the
Company's nominated adviser under the AIM Rules for Nominated
Advisers are owed solely to London Stock Exchange plc and are not
owed to the Company or to any director of the Company or to any
other person in respect of any decision to acquire shares in the
Company in reliance on any part of this announcement.
Shore Capital Group Limited, which is authorised and regulated
in the United Kingdom by the FCA, is acting as joint bookrunner and
joint broker to the Company in connection with the Placing and
Admission and to no-one else and will not be responsible to anyone
other than the Company for providing the protections afforded to
its clients, nor for providing advice in relation to the Placing or
Admission or any other matter referred to in this announcement.
Neither of the Joint Bookrunners or any of their directors,
officers, employees, advisers, affiliates or agents, accepts any
responsibility or liability whatsoever for or makes any
representation or warranty, express or implied, as to this
announcement, including the truth, accuracy or completeness of the
information in this announcement (or whether any information has
been omitted from the announcement) or for any loss howsoever
arising from any use of the announcement or its contents. The Joint
Bookrunners and their respective directors, officers, employees,
advisers, affiliates or agents, accordingly disclaim all and any
liability whether arising in tort, contract or otherwise which they
might otherwise have in respect of this announcement or its
contents or otherwise arising in connection therewith.
Data Protection
The processing of a Placee's personal data by the Company will
be carried out in compliance with the applicable data protection
legislation and with its Privacy Notice, a copy of which can be
found on the Company's website
https://www.velocys.com/privacy-policy/ .
Each Placee acknowledges that it has read and understood the
processing activities carried out by the Company as informed in the
referred Privacy Notice.
APPIX III
DEFINITIONS AND GLOSSARY
DEFINITIONS
The following definitions apply throughout this announcement
unless the context otherwise requires:
"Act" the UK Companies Act 2006, as amended
"Admission" Admission of the Placing Shares, the Retail
Offer Shares and the Open Offer Shares to
trading on AIM becoming effective in accordance
with Rule 6 of the AIM Rules
"AIM" the market of that name operated by the London
Stock Exchange
"AIM Rules" the AIM Rules for Companies, which set out
the rules and responsibilities for companies
listed on AIM, as amended from time to time
"Altalto Project" a waste to sustainable fuels biorefinery
project, located in Immingham, North East
Lincolnshire, UK, in development by the Group
in conjunction with commercial partners
"Application Form" the non-CREST application form relating to
the Open Offer and enclosed with the Circular
for use by Eligible Non-CREST Shareholders
"Articles" the articles of association of the Company
(as amended from time to time)
"Basic Entitlement" Entitlement to subscribe for Open Offer Shares,
allocated to an Eligible Shareholder pursuant
to the Open Offer on the Record Date as described
in Part III (Terms and Conditions of the
Open Offer) of the Circular
"Bayou Fuels Project" the Company's reference biorefinery project
in Natchez Mississippi, US
"Bechtel" Bechtel Limited
"Board" or "Directors" the board of directors of the Company, whose
names are listed in the Circular
"Bookbuild" the accelerated bookbuild process in relation
to the Placing, on the terms described in
the Placing Agreement and the other documents
relating to the Placing, which will establish
the number of Placing Shares to be issued
and allotted pursuant to the Placing
"British Airways" British Airways plc
"Carbon Direct Capital" Carbon Direct Fund II LP and Carbon Direct
Fund II-A LP
"Circular" the Circular to be published by the Company
on or about 22 May 2023 setting out details
of the Fundraise and containing the Notice
of the General Meeting
"CLN Investors" the investors subscribing for the Convertible
Loan Notes being Carbon Direct Capital and
any other investor who elects to subscribe
for Convertible Loan Notes or, if the Convertible
Loan Notes are transferred pursuant to the
terms set out in the Convertible Loan Note
Instrument, the registered holder(s) of the
Convertible Loan Notes from time to time
"CLN Long Stop Date" 30 September 2023 (which may be extended
to 31 December 2023 with the agreement of
the Company and Carbon Direct Capital)
"Commitment Letter" the conditional commitment letter dated 18
May 2023 between the Company and Carbon Direct
Capital pursuant to which Carbon Direct Capital
conditionally agrees to subscribe for a minimum
of $15 million of Convertible Loan Notes
"Company" or "Velocys" Velocys plc, a public limited company incorporated
in England & Wales under registered number
05712187 and having its registered office
at Magdalen Centre, Robert Robinson Avenue,
The Oxford Science Park, Oxford, England,
OX4 4GA
"Conversion" the conversion of the Convertible Loan Notes
into fully paid Ordinary Shares in accordance
with the provisions of the Convertible Loan
Note Instrument
"Conversion Price" a price per Ordinary Share equal to the Issue
Price of 2.5 pence or, if lower, the lowest
price per Ordinary Share at which the Company
issues Ordinary Shares to a Shareholder or
investor in connection with an equity fundraising
by way of the issue of new Ordinary Shares
in the Company, or the conversion or exercise
price for any further issue of convertible
loan notes or issue of warrants, if any,
which is completed after the date of the
Convertible Lon Note Instrument but prior
to Conversion
"Convertible Loan Note the convertible loan note instrument constituted
Instrument" by the Company on 18 May 2023 in respect
of the Convertible Loan Notes
"Convertible Loan Notes" convertible loan notes to be issued at a
price of $1 per loan note to the CLN Investors
pursuant to the Convertible Loan Note Instrument
"CREST" the relevant system (as defined in the Regulations)
which enables title to units of relevant
securities (as defined in the Regulations)
to be evidenced and transferred without a
written instrument and in respect of which
Euroclear UK & International Limited is the
Operator (as defined in the Regulations)
"Disclosure Guidance the Disclosure Guidance and Transparency
and Transparency Rules" Rules issued by the FCA
"Eligible CREST Shareholders" Eligible Shareholders whose Existing Ordinary
Shares are held in uncertificated form in
a CREST account
"Eligible Non-CREST Eligible Shareholders whose Existing Ordinary
Shareholders" Shares are held in certificated form
"Eligible Shareholders" Shareholders on the Ex-Entitlement Date that
are not resident in a jurisdiction outside
of the UK and that are not a Sanctioned Shareholder
"ENVIA" ENVIA Energy, LLC, a former joint venture
between Waste Management, Inc., NRG, Ventech
Projects Investments, LLC and the Group which
was liquidated in 2020
"Excess Entitlement" Open Offer Shares in excess of the Basic
Entitlement, but not in excess of the total
number of Open Offer Shares, allocated to
an Eligible Shareholder pursuant to the Open
Offer as described in Part III (Terms and
Conditions of the Open Offer) of the Circular
"Ex-Entitlement Date" the date on which the Ordinary Shares are
marked 'ex' for entitlement by the London
Stock Exchange under the Open Offer, being
23 May 2023
"Existing Ordinary the 1,397,671,031 Ordinary Shares in issue
Shares" as at the date of the Circular being the
entire issued share capital of the Company
prior to the Placing, the Retail Offer and
the Open Offer
"FCA" Financial Conduct Authority
"Final Maturity Date" the final maturity date of the Convertible
Loan Notes, being 36 months following the
issue of the relevant Convertible Loan Notes
"Form of Proxy" the accompanying form of proxy for use by
Shareholders in relation to the General Meeting
"FSMA" the Financial Services and Markets Act 2000
(as amended)
"Fundraise" the Placing, the Retail Offer, the Open Offer
and the proposed, conditional issue of the
Convertible Loan Notes to Carbon Direct Capital
and the potential further issuances of Convertible
Loan Notes and/or new Ordinary Shares to
investors other than Carbon Direct Capital
"General Meeting" the general meeting of the Company to be
held at 10.30 a.m. on 8 June 2023, notice
of which is set out at the end of the Circular,
and any adjournment thereof
"Group" Velocys plc and its subsidiaries
"Intermediary" an individual, company or other entity that
manages and executes the buying and selling
of securities on behalf of Retail Investors
"Issue Price" 2.5 pence per New Ordinary Share
"Joint Bookrunners" Panmure Gordon and Shore Capital
"Link Group" a trading name of Link Market Services Limited,
a company incorporated in England and Wales,
with registered number 02605568, whose registered
office is at Central Square, 10(th) Floor,
29 Wellington Street, Leeds, England, LS1
4DL
"London Stock Exchange" London Stock Exchange plc
"Maximum Amount" GBP50 million
"Minimum Amount" $40,000,000 less the amount subscribed for
by Carbon Direct Capital pursuant to the
Fundraise
"Minimum Amount Condition" the condition to the issuance of Convertible
Loan Notes to Carbon Direct Capital that
the Minimum Amount must be raised by the
Company or the Company must have received
legally binding commitments in respect of
the Minimum Amount from investors other than
Carbon Direct Capital by the CLN Long Stop
Date
"NEDO" the New Energy and Industrial Technology
Development Organization of Japan
"New Ordinary Shares" the Placing Shares, the Retail Offer Shares
and the Open Offer Shares to the extent subscribed
for under the Retail Offer and the Open Offer
as applicable
"Notice of General the notice of General Meeting set out at
Meeting" the end of the Circular
"Open Offer" the offer to Eligible Shareholders, constituting
an invitation to apply for the Open Offer
Shares at the Issue Price on the terms and
subject to the conditions set out in the
Circular and, in the case of Eligible Non-CREST
Shareholders, in the Application Form
"Open Offer Entitlements" entitlements to subscribe for Open Offer
Shares pursuant to the Basic Entitlement
and Excess Entitlement
"Open Offer Shares" up to 77,648,390 new Ordinary Shares to be
issued to Eligible Shareholders pursuant
to the Open Offer
"Ordinary Shares" ordinary shares of 1 pence each in the capital
of the Company
"Panmure Gordon" Panmure Gordon (UK) Limited, a private limited
company incorporated in England & Wales under
registered number 04915201 and having its
registered office at 40 Gracechurch Street,
London EC3V 0BT acting as Nominated Adviser,
Joint Bookrunner & Joint Broker
"Placing" the conditional placing of the Placing Shares
to placees
"Placing Agreement" the conditional agreement dated 18 May 2023
relating to the Placing, the Open Offer and
the Retail Offer, between the Company, Panmure
Gordon and Shore Capital
"Placing Documents" the marketing presentation used by the Company
in connection with the Placing, the Circular,
this announcement (including the appendices)
and the announcement of the results of the
Placing to be published by the Company following
completion of the Bookbuild
"Placing Long Stop 8.00 a.m. on 23 June 2023
Date"
"Placing Shares" the New Ordinary Shares to be issued, conditional
on Admission, in connection with the Placing
"Prospectus Regulation the Prospectus Regulation Rules made in accordance
Rules" with the Prospectus Regulation Rules Instrument
2019 (FCA: 2019/80)
"Receiving Agent" Link Group, Corporate Actions
"Record Date" 5.00 p.m. on 18 May 2023, being the record
date for the Open Offer
"Reference Projects" the Bayou Fuels Project and the Altalto Project,
the purpose of which are to accelerate adoption
of the Group's technology and to provide
a source of income to the Group
"Registrar" Link Group
"Regulations" the UK Uncertificated Securities Regulations
2001 (SI 2001 No. 3755), as amended
"Resolutions" the resolutions to be proposed at the General
Meeting as set out in the Notice of General
Meeting
"Retail Investors" investors in the usual type of an Intermediary's
client base, which may include individuals
aged 18 years or over, companies and other
bodies corporate, partnerships, trusts, associations
and other unincorporated organisations
"Retail Offer" the offer of the Retail Offer Shares, through
Intermediaries, to Retail Investors in the
United Kingdom who are Eligible Shareholders
in the Company (anticipated to be announced
in due course following the release of this
announcement)
"Retail Offer Shares" any Ordinary Shares to be issued by the Company
under the terms of the Retail Offer
"Sanctioned Shareholder" any Shareholder that is that is designated
under any asset freeze or blocking sanctions
imposed by the United States, United Kingdom,
European Union or any Member State thereof,
or is 50 per cent. or more owned, or otherwise
controlled, by one or more such designated
persons
"Shareholders" the holders of Ordinary Shares from time
to time, each individually being a "Shareholder"
"Shore Capital" Shore Capital Stockbrokers Limited, Joint
Bookrunner & Joint Broker
"Toyo" Toyo Engineering Corporation
"UK" or "United Kingdom" the United Kingdom of Great Britain and Northern
Ireland
"US" or "United States" the United States of America, its territories
and possessions, any state of the United
States and the District of Colombia
"US Listing" a listing of the Ordinary Shares or American
Depositary Shares ("ADSs") on the New York
Stock Exchange or NASDAQ
"EUR" the single currency of the participating
member states of the European Union
"$" the lawful currency of the United States
"GBP" the lawful currency of the United Kingdom
GLOSSARY
The terms set out below have the following meanings throughout
this announcement, unless the context requires otherwise.
"drop-in" fuel which can be placed into existing engines
and infrastructure without the need for
modification to them to use the fuel.
"EPC" engineering, procurement and construction
"feedstock" raw material processed ingested in the fuel-generation
process
"FID" final investment decision
"Fischer-Tropsch process" a process for producing liquid and gaseous
hydrocarbon fuels through chemical reactions
that converts a mixture of carbon monoxide
and hydrogen, known as syngas, into liquid
hydrocarbons
"FTI" the Fischer-Tropsch (FT) section of a plant,
the design of which is licensed by Velocys
to its customers, comprising multiple FT
reactors and ancillary equipment
"ITP" integrated technology package
"naphtha" a flammable liquid distillate of petroleum
"recyclates" materials capable of being recycled
"Renewable Fuel Standard" the US renewable fuel standard program created
under the Energy Policy Act 2005 and amended
by the Energy Independence and Security
Act 2007
"Renewable Identification a renewable identification number assigned
Number" or "RIN" to a batch of biofuel to track its production
use and trading as required by the Renewable
Fuel Standard
"Renewable Transport certificates awarded under the Renewable
Fuel Certificates" Transport Fuels Obligation
"Renewable Transport the UK Renewable Transport Fuel Obligation
Fuels Obligation" Order published 5 November 2012
"SAF" sustainable aviation fuel
APPENDIX IV
EXPECTED TIMETABLE OF PRINCIPAL EVENTS
Record Date for the Open Offer 4.30 p.m. on 18 May
2023
Announcement of the Fundraise 18 May 2023
Announcement of the results of the Placing 19 May 2023
and the Retail Offer
Dispatch of the Circular, Application Form 22 May 2023
and Proxy Form
Ex-Entitlement Date 8.00 a.m. on 23 May
2023
Basic Entitlements and Excess Entitlements as soon as possible
credited to stock accounts in CREST for Eligible after 8.00 a.m. on
CREST Shareholders 24 May 2023
Latest recommended time and date for requested 4.30 p.m. on 1 June
withdrawal of Basic Entitlements and Excess 2023
Entitlements from CREST
Latest time and date for depositing Basic 3.00 p.m. on 2 June
Entitlements and Excess Entitlements into 2023
CREST
Latest time for splitting Application Forms 3.00 p.m. on 5 June
(to satisfy bona fide market claims only) 2023
Last time and date for receipt of Form of 10.30 a.m. on 6 June
Proxy 2023
Latest time and date for receipt of Application 11.00 a.m. on 7 June
Form and payment in full under the Open Offer 2023
or settlement of relevant CREST instructions
(as appropriate)
General Meeting 10.30 a.m. on 8 June
2023
Announcement of results of the General Meeting 8 June 2023
and Open Offer
Admission and dealings in the Placing Shares, 8.00 a.m. on 9 June
the Retail Offer Shares and the Open Offer 2023
Shares to commence on AIM
CREST accounts credited with the Placing 9 June 2023
Shares, the Retail Offer Shares and the Open
Offer Shares
Definitive share certificates for the New w/c 12 June 2023
Ordinary Shares to be dispatched (if required)
Issue of Convertible Loan Notes to Carbon By 30 September 2023(5)
Direct Capital(4)
(1) References to are to London time (unless otherwise stated).
(2) The dates and timing of the events in the above timetable
and in the Circular are indicative only and may be subject to
change.
(3) If any of the above times or dates should change, the
revised times and/or dates will be notified by an announcement
through a Regulatory Information Service.
(4) This is subject to satisfaction of the conditions in the Commitment Letter
(5) This date can be extended to 31 December 2023 with the
agreement of the Company and Carbon Direct Capital
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEBLGDUSXBDGXI
(END) Dow Jones Newswires
May 18, 2023 12:40 ET (16:40 GMT)
Velocys (LSE:VLS)
Historical Stock Chart
From Apr 2024 to May 2024
Velocys (LSE:VLS)
Historical Stock Chart
From May 2023 to May 2024